US20040186551A1 - Multiple independent nested stent structures and methods for their preparation and deployment - Google Patents
Multiple independent nested stent structures and methods for their preparation and deployment Download PDFInfo
- Publication number
- US20040186551A1 US20040186551A1 US10/738,666 US73866603A US2004186551A1 US 20040186551 A1 US20040186551 A1 US 20040186551A1 US 73866603 A US73866603 A US 73866603A US 2004186551 A1 US2004186551 A1 US 2004186551A1
- Authority
- US
- United States
- Prior art keywords
- rings
- stent
- structures
- expansible
- axially extending
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/828—Means for connecting a plurality of stents allowing flexibility of the whole structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
- A61F2002/9583—Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
Definitions
- the present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for delivering a plurality of separate luminal prostheses within a body lumen, such as a blood vessel.
- Coronary artery disease is the leading cause of death and morbidity in the United States and Western society.
- atherosclerosis in the coronary arteries can cause myocardial infarction, commonly referred to as a heart attack, which can be immediately fatal or, even if survived, can cause damage to the heart which can incapacitate the patient.
- coronary artery bypass surgery can be an effective treatment for stenosed arteries resulting from atherosclerosis or other causes, it is a highly invasive procedure which is also expensive and which requires substantial hospital and recovery time.
- Percutaneous transluminal angioplasty commonly referred to as balloon angioplasty
- balloon angioplasty is less invasive, less traumatic, and significantly less expensive than bypass surgery.
- balloon angioplasty has not been considered as effective a treatment as bypass surgery.
- the effectiveness of balloon angioplasty has improved significantly with the introduction of stenting, which involves the placement of a scaffold structure within an artery that has been treated by balloon angioplasty.
- the stent inhibits abrupt reclosure of the artery and has some benefit in inhibiting subsequent restenosis resulting from hyperplasia.
- Presently available stents may be generally categorized as either “closed cell configurations” or “open cell configurations.” Closed cell configurations are characterized by ellipses, ovals, and polygonal structures, such as closed boxes, rhomboids, diamonds, and the like, which open in the circumferential direction and shorten in the axial direction as the stent is expanded. Open cell configurations include zigzag and serpentine structures which may be formed as a plurality of discreet rings or may be formed from a single continuous wire or other element. Closed cell stents are advantageous in that they provide better coverage of the blood vessel wall when the stent is deployed.
- U.S. Pat. Nos. 6,200,337 and 5,870,381 describe stents having closed cell rings with overlapping portions connected by axial connecting members.
- U.S. Pat. No. 6,375,676 describes a stent having open cell rings with overlapping portions connected by axial connecting members.
- U.S. Patent Application Publication Nos. 2002/0188343 and 2002/0188347 describe expandable stents having interconnecting elements which interlock circumferentially adjacent bridges between axially adjacent stent segments.
- U.S. Pat. No. 4,580,568 describes the sequential placement of a plurality of zigzag ring stents where the stents may optionally be overlapped (FIGS. 7 and 8).
- U.S. Pat. No. 6,319,277 describes a stent formed from a single element into a plurality of nested “waves.”
- U.S. Pat. No. 5,554,181 describes a stent formed from a single element into partially overlapping windings.
- Other patents of interest include U.S. Pat. Nos. 6,312,458; 5,879,370; 5,755,776; 5,507,771; and 5,104,404.
- U.S. Pat. No. 6,258,117 BI describes a stent having multiple sections connected by separable or frangible connecting regions. Optionally, the connecting regions are severed after the stent structure has been implanted in the blood vessel.
- the present invention provides methods and apparatus for prosthesis placement, such as stenting of body lumens, typically blood vessels, and more typically coronary arteries.
- the methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like.
- the terms “stent” and “stenting” are defined to include any of the wide variety of expandable prostheses and scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site.
- the stents and prostheses of the present invention commonly comprise a closed or, less preferably, an open lattice structure, and are typically formed from a malleable or elastic metal.
- a malleable metal such as stainless steel, gold, platinum, titanium, and super alloys
- the stents When formed from a malleable metal, such as stainless steel, gold, platinum, titanium, and super alloys, the stents will typically be expanded by a balloon which causes plastic deformation of the lattice so that it remains opened after deployment.
- an elastic metal including super elastic metals such as nickel-titanium alloys, the lattice structures will usually be radially constrained when delivered and deployed by releasing the structures from such radial constraint so that they “self-expand” at the target site.
- grafts When the stent or lattice structures are covered with a fabric or polymeric membrane covering, they are commonly referred to as grafts. Grafts may be used for the treatment of aneurysms or other conditions which require placement of a non-permeable or semi-permeable barrier at the treatment site.
- the terms “stent” and “stent structures” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within body lumens.
- the stents and stent structures of the present invention may have any of a variety of common constructions, including closed cell constructions such as expansible ovals, ellipses, box structures, expandable diamond structures, expandable rhomboid structures, as well as other regular and irregular polygonal structures, etc.
- the closed cells may have complex slotted geometries, such as H-shaped slots, I-shaped slots, J-shaped slots, etc.
- Suitable open cell structures include zigzag structures, serpentine structures, and the like.
- Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Pat.
- stents will comprise a plurality of independent expansible rings each having a length of 1 mm or greater, usually 2 mm or greater, and sometimes of 3 mm or greater, usually being in the range from 1 mm to 10 mm, typically from 2 mm to 7 mm, more typically from 2 mm to 5 mm.
- the use of such short ring lengths is advantageous since the overall stent length will be a multiple of the ring length.
- the methods and apparatus of the present invention will provide for the deployment of a plurality of stents or other prostheses from a common stent delivery catheter.
- the number of delivered stents will be in the range from 2 to 50, typically from 3 to 30, and most typically from 3 to 25.
- the individual stent length will often be somewhat less, although this is not necessarily the case in all instances.
- the multiple prostheses may be deployed individually or in groups of two or more at a single location or at multiple spaced-apart locations in the body lumen or lumens.
- stent structures will comprise a plurality of radially expansible rings, as generally described above, arranged along an axial line. Expansible rings are arranged adjacent to each other and will include axially extending elements which interleave or nest with similarly axially extending elements on adjacent rings.
- interleaved it is meant that the axially extending elements on adjacent rings will interpenetrate with each other in an axial direction, at least prior to stent expansion and preferably even after stent expansion.
- the interpenetrating elements will not overlap, i.e., be positioned one over another in the radial direction, but it is possible that in some implementations there may be some overlapping prior to or even after expansion.
- the axial interpenetration will be at least 0.1 mm, usually being at least 1 mm, and often being in the range from 1 mm to 5 mm, and will of course depend on the axial length(s) of the adjacent ring(s). Expressed as a percentage, the axial length of the axially extending elements will usually be at least 5% of the axial length of the ring, usually being from 5% to 50%, and preferably being from 20% to 30%.
- the axially extending elements on adjacent rings will interleave without interlocking so as to permit axial separation between the adjacent rings prior to expansion of the rings.
- axially extending elements may, in some instances, also interpenetrate in a peripheral direction prior to expansion.
- Such peripheral interpenetration can provide axial interlocking of the axially adjacent expansible rings prior to expansion. It will usually be desirable or even necessary that the peripheral interpenetration be relieved during radial expansion of the stent structures so that the independent rings be released from each other when deployed.
- a tether or other types of links may be provided to interconnect or otherwise restrain the rings even after expansion and deployment.
- each expansible ring will preferably comprise expansible closed cell structures, as set forth above. Less preferably, the expansible rings may comprise expansible open cell structures, as set forth above. The lengths and diameters of the individual rings have been set forth generally above.
- the stent structure will typically comprise from 2 to 50 individual rings, usually from 3 to 30 individual rings, and often from 3 to 25 individual rings.
- the spacing between adjacent rings may be uniform or non-uniform, preferably being uniform.
- the stent structures will be configured to shorten upon expansion to increase the spacing between rings. It is usually preferable that the edges of the adjacent rings not overlap, at least prior to deployment. Deployment of the stents, particularly in curved and tortuous luminal regions, may sometimes result in touching and overlapping of the stent rings.
- the stent structures may be modified in a variety of ways which are used with other conventional stents.
- some or all of the radially expansible rings may releasably carry a biologically active agent, such as an agent which inhibits hyperplasia.
- anti-hyperplasia agents include anti-neoplastic drugs, such as paclitaxel, methotrexate, and batimastal; antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin; amino suppressants such as dexamethasone and methyl prednisolone; nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like.
- anti-neoplastic drugs such as paclitaxel, methotrexate, and batimastal
- antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin
- amino suppressants such as dexamethasone and methyl prednisolone
- nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like.
- a stent deployment system comprises an elongate carrier having a central axis and including a plurality of radially expansible rings arranged over a surface thereof. At least some of the radially expansible rings will have the features and characteristics just described with respect to the present invention.
- the elongate carriers of the stent deployment systems will typically comprise a radially expansible balloon having an outer surface where the radially expansible rings are disposed over the outer surface of the balloon.
- the balloon may comprise a single inflation chamber in which case all of the rings will be expanded simultaneously.
- the balloon may comprise a plurality of independently inflatable chambers so that individual expansible rings may be deployed separately from the other rings.
- the elongated carrier of the stent deployment system may alternatively comprise a carrier tube having an inner surface which carries and constrains the radially expansible rings.
- the expansible rings will usually be self-expanding, i.e., held in a radially constrained configuration by the carrier tube prior to release and expansion at a luminal target site.
- the carrier tube structures will further comprise a pusher tube arranged to axially advance the radially expansible rings from the carrier tube.
- the elongated carrier may still further comprise a balloon arranged to receive and expand individual rings as they advance from the carrier tube, in which case the carrier may be used for delivering the formable (balloon-expansible) stent structures.
- such a balloon may also be used with self-expanding stent structures to control or enhance expansion, to perform predilatation of a lesion prior to stent deployment, or to further expand the stent structures and dilate the vessel lumen after the structures have self-expanded.
- multiple independent stent rings are arranged on a carrier by the following methods.
- An elongated carrier structure is provided and a plurality of radially expansible rings comprising axially extending elements are mounted on the carrier structure such that the axially extending elements on adjacent rings interleave or nest after they are mounted.
- the number of rings mounted on the carrier is selected to provide a desired overall stent length, and the number of rings is typically in the ranges set forth above, providing overall stent lengths in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.
- Other aspects of the individual radially expansible rings have been described above.
- methods for stenting a body lumen comprise delivering to the body lumen a stent structure having a plurality of radially expansible rings.
- the rings are as described above with respect to other aspects of the present invention, and at least some of the rings are expanded within the body lumen so that the axially extending elements open and axially move apart from each other as they radially expand.
- the length of the axially extending elements and degree of radial expansion will be selected so that the elements remain interleaved even after being fully expanded within the body lumen.
- Such an interleaving structure enhances the continuity of lumenal wall coverage provided by the deployed stent structure.
- Target body lumens are typically blood vessels, more typically arteries, such as coronary arteries.
- the rings may be delivered simultaneously, typically using a single inflatable balloon, or sequentially, typically using a carrier tube, pusher tube and optionally deployment balloon.
- Methods may be used for delivering from 3 to 50 rings, usually from 3 to 30 rings, and typically from 3 to 25 rings, to cover a luminal length in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.
- FIG. 1 is a schematic illustration of a stent structure according to the present invention comprising a plurality of closed cell ring structures.
- FIG. 2 illustrates the stent structure of FIG. 1 shown in its radially expanded configuration.
- FIGS. 2A and 2B illustrate the difference in deployed configuration of non-nested and nested stent structures, respectively.
- FIG. 3 illustrates a stent structure constructed in accordance with the principles of the present invention comprising a plurality of open cell expansible rings.
- FIG. 4 illustrates the stent structure of FIG. 3 shown in its radially expanded configuration.
- FIG. 5 illustrates a first exemplary expansible ring structure in accordance with the principles of the invention.
- FIG. 6 illustrates a stent structure comprising a plurality of the ring structures of FIG. 5, shown in a rolled out radially collapsed configuration.
- FIGS. 6A and 6B illustrate variations on the ring structure of FIG. 6, where the variations are chosen to inhibit axial separation of the ring structures prior to deployment.
- FIG. 7 illustrates the stent structure of FIG. 6 shown in its radially expanded configuration.
- FIG. 8 illustrates a second exemplary expansible ring structure in accordance with the principles of the present invention.
- FIG. 9 illustrates a stent structure comprising a plurality of the rings of FIG. 8.
- FIG. 10 illustrates the stent structure of FIG. 8 in its radially expanded configuration.
- FIGS. 11-14 illustrate further exemplary expansible ring structures in accordance with the principles of the present invention.
- FIGS. 15A and 15B illustrate a further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
- FIGS. 16A and 16B illustrate a still further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
- FIGS. 17A and 17B illustrate deployment of a closed cell stent structure according to the present invention with both a balloon having a single chamber (FIG. 16) and a balloon having multiple chambers to permit selective delivery of portions of the stent structure (FIG. 17).
- FIGS. 18A-18D illustrate deployment of a plurality of a expansible rings which form a stent structure according to the present invention using a delivery tube and pusher tube in combination with an expansion balloon.
- FIG. 19 illustrates a kit constructed in accordance with the principles of the present invention.
- FIGS. 20A-20B, 21 A- 21 B, and 22 A- 22 B illustrate further embodiments of stent structures according to the invention in unexpanded and expanded configurations.
- the present invention provides apparatus, systems, and methods for preparing and delivering stent structures comprising a plurality of “separate” or “discreet” radially expansible ring segments.
- “separate” or “discreet” it is meant that the ring segments are unconnected (or easily disconnected) at the time they are delivered to a target body lumen.
- the ring segments will be closely packed to provide a relatively high degree of vessel wall coverage after they are expanded. By disconnecting the adjacent segments, however, such a tightly packed structured can retain a very high degree of flexibility permitting delivery and conformance in even highly torturous regions of the vasculature and other body lumens.
- the ability to closely pack the expansible ring segments and achieve a high degree of vessel wall coverage is achieved at least partly because at least some of the axially adjacent rings comprise axially extending elements which interleave or nest with axially extending elements on an adjacent connected ring.
- the axially extending elements will be formed from a radially expansible portion of the ring, e.g., the element will be part of the closed cell structure or open cell structure as described in more detail hereinbelow.
- these expansible sections will typically foreshorten as they are radially expanded, interleaving and nesting the segments on adjacent rings prior to expansion minimizes or preferably eliminates any gaps in coverage after the stent is expanded, as described in more detail below.
- the stent structures of the present invention may be fabricated as either balloon-expansible or self-expanding stents according to methods well known in the art.
- Typical deformable materials suitable for fabricating balloon-expansible stent structures include 316L stainless steel, gold, platinum, cobalt chrome, platinum, and the like.
- Suitable resilient materials for self-expanding stents include nickel titanium alloys, various spring stainless steel alloys, Eligloy® alloy, and the like. It will also be possible to form the stent structures of the present invention from both natural and synthetic polymers. Natural polymers include collagen, gelatin, chitin, cellulose, and the like.
- Suitable synthetic polymers include polyglycolic acids (PGA), polylactic acids (PLA), poly ethylene glycols (PEG), polyamides, polyimides, polyesters, and the like. In some instances, it would be possible to form different radially expansible segments from different materials in order to achieve different properties.
- the stent structures will comprise a plurality of the individual radially expansible ring segments with typical dimensions, numbers, and the like, described above in the summary.
- the plurality of ring segments will be arranged prior to delivery, in a manner suitable for delivery to and deployment within a target blood vessel or other body lumen.
- the plurality of radially expansible rings will be arranged along an axial line, typically defined by a deployment balloon, a delivery tube, or some combination thereof.
- the expansible ring segments will be arranged so that the axially extending elements on each of the segments is interleaved with corresponding axial extending elements on adjacent but unconnected ring segments. Referring now to FIGS. 1-4, such arrangements will be generally described for both closed cell ring structures (FIGS. 1 and 2) and open cell ring structures (FIGS. 3 and 4).
- FIG. 1 a portion of a stent structure 10 comprising a plurality of radially expansible rings 12 is illustrated.
- Each radially expansible ring 12 includes a plurality of closed rhomboid or diamond structures 14 circumferentially joined by connectors 16 .
- the stent structure 10 is shown in a “rolled-out” configuration, and that only a portion of the structure is depicted for simplicity.
- the stent structure would contain a greater number of expansible rings 12 , and each ring would include a larger number of rhomboid cells.
- FIG. 1 illustrates that each rhomboid cell 14 includes an axially extending element 18 which interleaves with a similar element on an adjacent ring structure.
- This interleaved structure permits a very close packing of the rings without the need to physically attach the rings.
- the axially extending elements 18 will usually continue to axially interleave which increases the coverage of the body lumen wall being treated.
- FIGS. 2A and 2B An expanded, non-interleaved multiple ring stent is shown in FIG. 2A. Substantial gaps G appear between the axially extending elements 18 on the large diameter side of the curved vessel segment.
- the nested stent configurations of the present invention are able to maintain interleaving of the axially extending elements 18 , even on the large diameter side of the curved vessel segment, as shown in FIG. 2B. While the present invention cannot assure that gaps will always be eliminated, the number and extent of the gaps will at least be reduced, thus improving wall coverage.
- a stent structure 20 comprising a plurality of open cell zigzag ring structures 22 , shown in FIGS. 3 and 4.
- Each zigzag ring includes axially extending elements which alternate directions, and the rings are arranged so that the elements are “nested” as shown in FIG. 3.
- the nested axially extending elements of the rings 22 remain generally overlapping, as shown in FIG. 4, even when the stent has undergone significant radial expansion.
- prior stent structures have utilized nested zigzag structures, they have generally either connected adjacent structures or utilized only a single filament for forming such structures. In neither case can the flexibility achieved by the present invention in combination with the ability to selectively deliver independent radially expansible segments be achieved.
- Each ring 32 comprises a plurality of closed cell boxes 34 joined at their midpoints by circumferentially directed connectors 36 .
- Each box 34 includes a central opening 35 which is generally an axial cut enlarged at each end and in the middle.
- the ring structure 32 is shown in its rolled-out or flattened configurations. In the actual stent structure, the ring would be rolled so that the “broken” connectors 34 ′ are in fact connected to form a cylindrical shape.
- the “bow tie” shape of the central opening 35 is advantageous as it permits maximum radial compression of the stent while minimizing both the delivery profile and the stress relief of the stent during expansion in the body lumen.
- FIG. 6 illustrates the very tight packing of the stent structure 30 that can be achieved.
- the stent structure 30 in FIG. 6 is in its pre-deployment configuration as it would be when placed over a balloon or within a delivery tube, as described in more detail hereinbelow. It can be seen that virtually all of the available area for carrying the stent is covered. Thus, when the stent is expanded as shown in FIG. 7, the area of the blood vessel or other luminal wall will be maximized. Moreover, this very close packing of the stent is achieved while concurrently providing a very high degree of flexibility while the stent is being delivered and conformability after the stent is deployed.
- Axial separation of the rings 32 of stent structure 30 can be inhibited by modifying the ring geometries in a variety of ways, such as shown in FIGS. 6A and 6B.
- the boxes 34 a are fabricated (or deformed after fabrication) to collapse near the centers so that they form “bow tie” structures, with enlarged ends 34 b interlocking.
- the boxes 34 c can be inclined relative to the axial direction, as shown in FIG. 6B, to also provide interlocking of adjacent rings prior to deployment. Such inclination can be used with at least most of the embodiments of the present invention to improve axial retention.
- other patterns such as chevrons, interleaved sigmoidal shapes, and the like could also be used to provide the desired interlocking prior to stent expansion.
- Stent structure 40 (FIG. 9) comprises a plurality of open cell expansible rings 42 formed in a “castellated” pattern, as shown in more detail in FIG. 8.
- the castellations comprise narrow U-shaped loops 44 and 46 which alternatively extend in a right hand direction (loop 44 ) and left hand direction (loop 46 ) relative to a circumferential center line 48 .
- the rings 42 are arranged so that the loops 44 and 46 overlap, as shown in FIG. 9, to form a tightly packed configuration. When expanded, as shown in FIG.
- the loops 44 and 46 continue to overlap to provide a very high degree of vessel wall coverage, as shown in FIG. 10.
- the open cell configuration of FIGS. 8-10 will also improve coverage in curved vessels, minimizing gaps as discussed previously.
- the length of the open cells will be in the range from 0.5 to 10 mm, usually from 2 to 5 mm.
- Ring structure 50 of FIG. 11 comprises a plurality of closed cell box elements 52 joined by circumferential connectors 54 and 56 .
- Ring 50 is similar to ring 32 of FIG. 5, except that the circumferential connectors 54 are split to form H-shaped slots 55 which span pairs of adjacent box structures 52 and the intermediate connectors 54 form a single, larger cell structures.
- Such larger openings are advantageous when stenting in blood vessels with side branches which must be kept open.
- the side branches may be accessed by opening the slots 55 with a balloon structure.
- the cell pattern of stent 32 (FIG. 5) provides a greater coverage that may be of particular importance with drug eluting stents.
- Stent structures comprising multiple rings 50 are shown in their unexpanded and expanded configuration in FIGS. 1A and 11B, respectively.
- the open slots 55 (FIG. 11B) provide for significant additional expansion (via balloon dilation or other subsequent intervention) in order to provide access to a side branch or for any other purpose.
- a further expanded slot 55 is shown in FIG. 11C, as expanded by balloon B.
- Ring structure 60 of FIG. 12 comprises a plurality of interconnected box structures 62 , 64 , and 66 .
- Each of the box structures shares common axial struts or beams, but the axially offset nature of the three box structures permits radial expansion.
- the box structures 62 and 66 provide the axially extending elements which may be interleaved in forming a stent structure from a plurality of the rings 60 .
- Axially extending elements 62 and 66 interleave and mate so that interleaved extending elements of adjacent stents can be interference fit with each other to provide a friction fit which inhibits separation of the stents, or be kept out of contact to allow for separation.
- extending elements can deflect radially inward which will provide additional adherence to an expandable delivery balloon and increased stent retention.
- Ring structure 70 in FIG. 13 comprises paired, symmetric box structures 72 and 74 joined by short circumferential connectors 76 .
- Each of the box structures 72 and 74 define a long and a short axially extending member which can be aligned with each other when forming a stent structure from a plurality of the rings 70 .
- This particular structure will provide good adherence to an expandable delivery balloon during deployment and have many of the same advantages as the embodiment of FIG. 12.
- Ring structure 80 of FIG. 14 is similar to that of ring structure 70 of FIG. 13, except that the “longer” rings terminate in a retainer, such as T-ends 82 .
- T-ends When deploying multiple rings 80 in a stent structure, the T-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Moreover, since the interlocking structures are not actually attached, they permit a high degree of flexibility while the stent is being deployed. While T-ends are shown in FIG. 14, the terminal retainers could be L- or J-shaped ends or have any other geometry, which also provides for interlocking.
- each of these geometries will include a peripherally extending segment 83 which interlocks with a peripherally extending segment 83 on an adjacent T-end 82 .
- the segment 83 will move apart allowing the adjacent rings to deploy separately.
- the T-, L- or J-ends will interlock to help hold the ring in place on the balloon or within the delivery tube.
- the interlock does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Such interlocking could also incorporated in the embodiments of FIGS. 5, 8, 11 and 12 .
- the stent structures have generally maximized to vessel wall coverage achieved after expansion. While this will often be desired, in some instances it may be desired to lessen the amount of wall coverage.
- a stent structure 90 includes independent rings 92 having boxes 93 circumferentially separated by spacers 94 .
- the spacers 94 will either not expand or expand only after the boxes 93 have expanded, thus maintaining an axial distance D between adjacent rings after expansion, as shown in FIG. 15B.
- the distance D will be equal to about one-half the total axial length of the spacer 94 .
- Stent structure 96 (FIGS. 16A and 16B) is similar to structure 90 , except that spaces 97 are axially split to define an H-shaped cell (as discussed with earlier embodiments) and certain of the rings 98 and joined by sigmoidal links 99 .
- Stent structures according to the present invention may be delivered in a variety of ways. As illustrated in FIGS. 17A-17C, the stent structure 30 may be delivered on a balloon catheter 90 having a balloon 92 with a single inflation chamber. Deployment of the stent 30 is illustrated in FIG. 17B where all independent ring structures 32 are expanded simultaneously. Alternatively, as illustrated in FIG. 17C, catheter may carry a balloon 94 having a plurality of independently inflatable compartments. In that way, one or more of the independent compartments may be inflated separately from others of the compartments to selectively deploy one, two, three, or more of the independent ring structures 32 . In that case, others of the ring structures 32 will remain unexpanded and available for separate expansion or may be simply removed from the patient if unused.
- FIGS. 18A-18D an alternative stent structure delivery protocol employing a carrier tube will be described.
- Such delivery protocols are described in more detail in co-pending application Ser. No. 10/306,813, filed on Nov. 27, 2002 (Attorney Docket Number 021629-000320US), and in copending application Ser. No. 10/637,713, filed Aug. 8, 2003 (Attorney Docket No. 21629-000340US), the full disclosures of which are incorporated herein by reference.
- Catheter 160 (FIG. 18A) comprises a sheath 164 , pusher tube 166 , and a catheter body 168 .
- the catheter body 168 includes an expansible balloon 170 over its distal portion.
- Individual expansible rings are deployed, as illustrated in FIGS. 18B and 18C, by first advancing the distal-most ring 162 using the pusher tube 166 .
- the catheter body 168 is also distally advanced so that a distal portion of the balloon 170 lies within the distal-most deployed ring 162 , as shown in FIG. 18B.
- the remaining proximal portion of the balloon 170 will, of course, remain within the other rings 162 which themselves remain within the sheath 164 .
- the balloon 170 is then inflated, but only the advanced distal portion of the balloon inflates within the advanced ring 162 , as illustrated in FIG. 18C. Expansion of the remaining proximal portion of the balloon is prevented by the sheath 164 .
- the remaining rings 162 remain unexpanded since they remain within the sheath 164 .
- additional rings 162 may be deployed, either at the same target location within the blood vessel or at a different, spaced-apart locations within the blood vessel. Deployment of two rings 162 is illustrated. The two rings 162 are axially advanced using the pusher tube 162 so that they are positioned over the uninflated balloon 170 . The balloon 170 is then inflated, as illustrated in FIG. 18D, thus expanding the rings 162 within the blood vessel BV.
- the catheter 160 could carry many more than the four illustrated rings 162 , and three, four, five, ten, and even 20 or more individual rings could be deployed at one time, with additional single prostheses or groups of prostheses being deployed at different times and/or at different locations within the blood vessel.
- the use of “stent valves” as described in application Ser. No. 10/306,813, previously incorporated herein by reference, may preferably be employed to facilitate controlling the number of rings deployed and the spacing between the deployed and undeployed rings.
- kits 200 comprise a catheter 160 (or a balloon catheter) in combination with instructions for use IFU.
- the instructions for use set forth any of the methods of the present invention, and in particular set forth how the catheter 160 may be used to implant a stent structure comprising multiple rings within a blood vessel or other body lumen.
- the catheter 160 and instructions for use will typically be packaged together, for example within a conventional package 202 , such as a box, tube, pouch, tray, or the like.
- Catheter 160 will typically be maintained in a sterile condition within the package 202 .
- the instructions for use may be provided on a package insert, may be printed in whole or in part on the packaging, or may be provided in other ways, such as electronically over the internet, on an electronic medium, such as a CD, DVD, or the like.
- FIG. 20A illustrates a portion of a stent segment 201 in an unexpanded configuration, shown in a planar shape for clarity.
- Stent segment 201 comprises two parallel rows 203 A, 203 B of I-shaped cells 205 formed around an axis A so that stent segment 201 has a cylindrical shape.
- I-shaped and H-shaped as used herein may refer to a similar cell geometry comprising two generally parallel slots connected by an interconnecting slot. Such cells may appear H-shaped when axis A is in a vertical orientation, or I-shaped axis A is in a horizontal orientation.
- Each cell 205 has upper and lower axial slots 207 aligned with the axial direction and a circumferential slot 204 .
- Upper and lower slots 207 preferably have an oval, racetrack, rectangular or other oblong shape with a long dimension L generally parallel to axis A and a short dimension W perpendicular thereto.
- Axial slots 207 are bounded by upper axial struts 206 A and lower axial struts 206 B, curved outer ends 208 and curved inner ends 210 .
- Each circumferential slot 204 is bounded by an outer circumferential strut 209 and an inner circumferential strut 211 .
- Each I-shaped cell 205 is connected to the adjacent I-shaped cell 205 in the same row 98 A or 98 B by a circumferential connecting strut 213 . All or a portion of cells 205 in row 98 A merge or join with cells 205 in row 98 B at the inner ends 210 , which are integrally formed with the inner ends 210 of the adjacent cells 205 .
- Stent segment 201 is configured to interleave with an adjacent stent segment of similar construction.
- Upper and lower axial struts 206 A, 206 B and outer ends 208 form axial elements E that are received in the spaces S between each element E of the adjacent stent segment 201 .
- a spacing member 212 extends outwardly in the axial direction from a selected number of outer circumferential struts 209 and/or connecting struts 213 .
- Spacing member 212 preferably itself forms a subcell 214 in its interior, but alternatively may be solid without any cell or opening therein.
- subcell 214 preferably communicates with I-shaped cell 205 .
- Spacing members 212 are configured to engage the curved outer ends 208 of an adjacent stent segment 201 so as to maintain appropriate spacing between adjacent stent segments.
- spacing members 212 have outer ends 216 with two spaced-apart protrusions 218 that provide a cradle-like structure to index and stabilize the curved outer end 208 of the adjacent stent segment.
- spacing members 212 have an axial length of at least about 10%, more preferably at least about 25%, of the long dimension L of I-shaped cells 205 , so that the I-shaped cells 205 of adjacent stent segments are spaced apart at least that distance. This results in elements E interleaving a distance of at least about 10%, preferably at least about 25%, and more preferably at least about 50% of their axial length as measured from the circumferential connecting struts 213 . Because spacing members 212 experience little or no axial shortening during expansion of stent segments 201 , this minimum spacing between stent segments is maintained both in the unexpanded and expanded configurations.
- FIG. 20B shows stent segment 201 of FIG. 20A in an expanded configuration. It may be seen that cells 205 are expanded so that upper and lower slots 207 are diamond shaped with circumferential slots 204 remaining basically unchanged. This results in some axial shortening of the stent segment, thereby increasing the spacing between adjacent stent segments.
- the stent geometry is optimized by balancing the amount of axial shortening and associated inter-segment spacing, the desired degree of vessel wall coverage, the desired metal density, and other factors. Because the stent is comprised of multiple unconnected stent segments 201 , any desired number from 2 up to 10 or more stent segments may be deployed simultaneously to treat lesions of any length from 2 mm up to 100 mm or more. Further, because such segments are unconnected to each other, the deployed stent structure is highly flexible and capable of deployment in long lesions having curves and other complex shapes.
- circumferential slots 204 provide a pathway through which vessel side branches can be accessed for catheter interventions.
- a balloon dilatation catheter may be positioned through circumferential slot 204 and expanded. This deforms circumferential struts 209 , 211 axially outward, thereby expanding circumferential slot 204 and further expanding upper and lower slots 207 , as shown in phantom in FIG. 20B.
- This provides a relatively large opening 220 through which a catheter may be inserted through stent segment 201 and into the side branch for placing stents, performing angioplasty, or carrying out other interventions.
- FIGS. 21A-21B illustrate a second embodiment of a stent segment 201 ′ according to the invention.
- two stent segments 201 ′ are shown interleaved in a planar shape for clarity.
- stent segment 201 ′ comprises two parallel rows 222 A, 222 B of I-shaped cells 224 formed into a cylindrical shape around axial axis A.
- Cells 224 have upper and lower axial slots 226 and a connecting circumferential slot 228 .
- Upper and lower axial slots 226 are bounded by upper axial struts 230 , lower axial struts 232 , curved outer ends 234 , and curved inner ends 236 , forming axial elements E configured to be received in spaces S between elements E in the adjacent stent segment 201 ′.
- Circumferential slots 228 are bounded by an outer circumferential strut 238 and inner circumferential strut 240 .
- Each I-shaped cell 224 is connected to the adjacent I-shaped cell 224 in the same row 222 by a circumferential connecting strut 242 .
- Row 222 A is connected to row 222 B by the merger or joining of curved inner ends 236 of at least one and preferably two of slots 226 in each row 222 .
- FIGS. 21A-21B differs from that of FIGS. 20A-20B in that of FIGS. 20A-20B in that of the adjacent interleaved stent segments.
- the embodiment of FIG. 21A includes a bulge 244 in upper and lower axial struts 230 , 232 extending circumferentially outwardly from axial slots 226 . These give axial slots 226 an arrowhead or cross shape at their inner and outer ends.
- each upper axial strut 230 extends toward the bulge 244 in a lower axial strut 232 in the same cell 205 or in an adjacent cell 205 , thus narrowing the space S therebetween and creating a concave abutment 246 in the space between each axial slot 226 .
- Concave abutments 246 are configured to receive and engage curved outer ends 234 of cells 224 in the adjacent stent segment, thereby maintaining spacing between the stent segments.
- the axial location of bulges 244 along upper and lower axial struts 230 , 232 may be selected to provide the desired degree of inter-segment spacing.
- the axial depth of concave abutments 246 from curved outer ends 234 is at least about 10% of the axial length of elements E (measured from circumferential struts 242 ), preferably at least about 25% of the axial length of elements E, and more preferably at least about 50% of the axial length of elements E.
- FIG. 21B shows two stent segments 201 of FIG. 21A in an expanded condition. It may be seen that axial slots 226 are deformed into a circumferentially-widened modified diamond shape with bulges 244 on the now diagonal upper and lower axial struts 230 , 232 . Circumferential slots 228 are generally the same size and shape as in the unexpanded configuration. Bulges 244 have been pulled away from each other to some extent, but still provide a concave abutment 246 to maintain a minimum degree of spacing between adjacent stent segments. As in the earlier embodiment, some axial shortening of each segment occurs upon expansion and stent geometry can be optimized to provide the ideal intersegment spacing.
- stent segments 201 ′ retain some degree of interleaving in the expanded configuration, with outer ends 234 of elements E on adjacent stent segments being at least circumferentially aligned with each other, and preferably extending into spaces S of the adjacent stent segment a distance of at least about 1%, more preferably at least about 5%, and in some cases at least about 10% of the axial length of elements E as measured from circumferential connecting struts 242 .
- elements E have an axial length of about 1 mm and are interleaved a distance D u of about 0.1-0.5 mm in the unexpanded configuration.
- Segments 201 ′ are expandable to a diameter of 2.5-3.5 mm and elements E are interleaved a distance De of about 0.01-0.1 mm in the expanded configuration.
- FIGS. 21A-21B retains the feature described above with respect to FIGS. 20A-20B to enable access to vessel side branches blocked by stent segment 201 ′. Should such side branch access be desired, a dilatation catheter may be inserted into circumferential slot 228 and expanded to provide an enlarged opening through which a side branch may be entered.
- FIGS. 22A-22B illustrate a variant of the stent structure of FIGS. 21A-21B that has a larger expanded diameter.
- the primary difference in the embodiment of FIGS. 22A-22B is the geometry of the inner ends 236 ′ of each axial slot 226 ′. Rather than being curved, inner ends 236 ′ are generally straight and oriented in the circumferential direction. Because of the longer circumferential dimension of the inner ends 236 ′, an inner portion 250 of each axial strut 230 ′, 232 ′ is disposed at an angle relative to the axial direction, giving the inner half 252 of each axial slot 226 ′ a trapezoidal shape.
- bulges 244 ′ are disposed along axial struts 230 ′, 232 ′ so as to create concave abutments 246 ′ that engage the outer ends 234 ′ of axial slots 226 ′ and maintain inter-segment spacing.
- stent segment 201 ′′ expands to a configuration similar to that of FIG. 21B, with the exception that inner ends 236 ′ remain generally straight and aligned with the circumferential direction.
- Axial slots 226 ′ are again expanded into a modified diamond shape, with bulges 244 ′ extending into spaces S to maintain inter-segment spacing.
- stent segment 201 ′′ has a length of about 4 mm and diameter of about 1.0-2.0 mm when unexpanded, and is expandable to a diameter of about 3.0-4.0 mm.
- the stent structures of the invention are preferably radiopaque so as to be visible by means of fluoroscopy.
- Radiopaque markers and/or materials may be used in or on the stent structures. Markers of radiopaque materials may be applied to the exterior of the stents, e.g, by applying a metal such as gold, platinum, a radiopaque polymer, or other suitable coating or mark on all or a portion of the stents.
- the stent structures may include a radiopaque cladding or coating or may be composed of radiopaque materials such as MP35N (ASTM 562 ), L- 605 cobalt chromium (ASTM F90), other suitable alloys containing radiopaque elements, or multilayered materials having radiopaque layers.
- the stent structures may have a geometry conducive to fluoroscopic visualization, such as having struts of greater thickness, sections of higher density, or overlapping struts.
- F1472- 02 a Wrought Titanium-6 Aluminum-4 Vanadium Alloy
Abstract
Blood vessels and other body lumens are stented using stent structures comprising a plurality of radially expansible rings where at least some of the rings comprise axially extending elements which interleave with axially extending elements on adjacent unconnected rings. The ring structures may be open cell structures or closed cell structures, and the axially extending elements will typically be formed as part of the open cell or closed cell structure.
Description
- This application claims the priority benefit of U.S. Provisional Patent Application No. 60/440,839 (Attorney Docket No. 21629-000500US), filed Jan. 17, 2003, entitled “Multiple Independent Nested Stent Structures & Methods for Their Deployment,” which application is hereby incorporated fully by reference.
- 1. Field of the Invention
- The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for delivering a plurality of separate luminal prostheses within a body lumen, such as a blood vessel.
- Coronary artery disease is the leading cause of death and morbidity in the United States and Western society. In particular, atherosclerosis in the coronary arteries can cause myocardial infarction, commonly referred to as a heart attack, which can be immediately fatal or, even if survived, can cause damage to the heart which can incapacitate the patient.
- While coronary artery bypass surgery can be an effective treatment for stenosed arteries resulting from atherosclerosis or other causes, it is a highly invasive procedure which is also expensive and which requires substantial hospital and recovery time. Percutaneous transluminal angioplasty, commonly referred to as balloon angioplasty, is less invasive, less traumatic, and significantly less expensive than bypass surgery. Heretofore, however, balloon angioplasty has not been considered as effective a treatment as bypass surgery. The effectiveness of balloon angioplasty, however, has improved significantly with the introduction of stenting, which involves the placement of a scaffold structure within an artery that has been treated by balloon angioplasty. The stent inhibits abrupt reclosure of the artery and has some benefit in inhibiting subsequent restenosis resulting from hyperplasia.
- Presently available stents may be generally categorized as either “closed cell configurations” or “open cell configurations.” Closed cell configurations are characterized by ellipses, ovals, and polygonal structures, such as closed boxes, rhomboids, diamonds, and the like, which open in the circumferential direction and shorten in the axial direction as the stent is expanded. Open cell configurations include zigzag and serpentine structures which may be formed as a plurality of discreet rings or may be formed from a single continuous wire or other element. Closed cell stents are advantageous in that they provide better coverage of the blood vessel wall when the stent is deployed. This is particularly advantageous in tightly curved segments of the vasculature where even stent coverage in both the axial and circumferential directions on the outer wall of the vessel has been shown to reduce restenosis. Such even coverage is also an advantage in achieving uniform delivery from drug eluting stents. In contrast, open cell stent configurations are generally more flexible than the closed cell configurations. Such flexibility is advantageous in the tortuous regions of the vasculature where enhanced flexibility can provide better conformance to the vessel being treated. Better conformance can reduce the stress on the vessel wall, particularly at the stent ends, and lead to reduced restenosis.
- For these reasons, it would be desirable to provide improved stents and stent structures. In particular, it would be desirable to provide stents and stent structures which combine the improved wall coverage of closed cell stent structures with the increased flexibility of open cell stent structures. It would be still further desirable if such improved stent structures allowed a physician to optimize the length of vessel being treated in accordance with the nature of the disease, allowed for the delivery of both very short and very long stent structures, and optionally permited delivery of stent structures at multiple contiguous and/or non-contiguous locations within a body lumen. At least some of these objectives will be met by the inventions described hereinafter.
- 2. Description of the Background Art
- U.S. Pat. Nos. 6,200,337 and 5,870,381 describe stents having closed cell rings with overlapping portions connected by axial connecting members. U.S. Pat. No. 6,375,676 describes a stent having open cell rings with overlapping portions connected by axial connecting members. U.S. Patent Application Publication Nos. 2002/0188343 and 2002/0188347 describe expandable stents having interconnecting elements which interlock circumferentially adjacent bridges between axially adjacent stent segments. U.S. Pat. No. 4,580,568 describes the sequential placement of a plurality of zigzag ring stents where the stents may optionally be overlapped (FIGS. 7 and 8). U.S. Pat. No. 6,319,277 describes a stent formed from a single element into a plurality of nested “waves.” U.S. Pat. No. 5,554,181 describes a stent formed from a single element into partially overlapping windings. Other patents of interest include U.S. Pat. Nos. 6,312,458; 5,879,370; 5,755,776; 5,507,771; and 5,104,404. U.S. Pat. No. 6,258,117 BI describes a stent having multiple sections connected by separable or frangible connecting regions. Optionally, the connecting regions are severed after the stent structure has been implanted in the blood vessel. U.S. Pat. Nos. 5,571,086; 5,776,141, and 6,143,016 describe an expandable sleeve for placement over a balloon catheter for the delivery of one or two stent structures to the vasculature. U.S. Pat. No. 5,697,948, describes a catheter for delivering stents covered by a sheath.
- The present invention provides methods and apparatus for prosthesis placement, such as stenting of body lumens, typically blood vessels, and more typically coronary arteries. The methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like. The terms “stent” and “stenting” are defined to include any of the wide variety of expandable prostheses and scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site. The stents and prostheses of the present invention commonly comprise a closed or, less preferably, an open lattice structure, and are typically formed from a malleable or elastic metal. When formed from a malleable metal, such as stainless steel, gold, platinum, titanium, and super alloys, the stents will typically be expanded by a balloon which causes plastic deformation of the lattice so that it remains opened after deployment. When formed from an elastic metal, including super elastic metals such as nickel-titanium alloys, the lattice structures will usually be radially constrained when delivered and deployed by releasing the structures from such radial constraint so that they “self-expand” at the target site. When the stent or lattice structures are covered with a fabric or polymeric membrane covering, they are commonly referred to as grafts. Grafts may be used for the treatment of aneurysms or other conditions which require placement of a non-permeable or semi-permeable barrier at the treatment site. The terms “stent” and “stent structures” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within body lumens.
- The stents and stent structures of the present invention may have any of a variety of common constructions, including closed cell constructions such as expansible ovals, ellipses, box structures, expandable diamond structures, expandable rhomboid structures, as well as other regular and irregular polygonal structures, etc. In addition, the closed cells may have complex slotted geometries, such as H-shaped slots, I-shaped slots, J-shaped slots, etc. Suitable open cell structures include zigzag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Pat. Nos. 6,315,794; 5,980,552; 5,836,964; 5,527,354; 5,421,955; 4,886,062; and 4,776,337. Preferred structures are described herein with reference to FIGS. 4 and 5.
- According to one aspect of the present invention, stents will comprise a plurality of independent expansible rings each having a length of 1 mm or greater, usually 2 mm or greater, and sometimes of 3 mm or greater, usually being in the range from 1 mm to 10 mm, typically from 2 mm to 7 mm, more typically from 2 mm to 5 mm. The use of such short ring lengths is advantageous since the overall stent length will be a multiple of the ring length.
- The methods and apparatus of the present invention will provide for the deployment of a plurality of stents or other prostheses from a common stent delivery catheter. Usually, the number of delivered stents will be in the range from 2 to 50, typically from 3 to 30, and most typically from 3 to 25. As more stents are placed on the delivery catheter, the individual stent length will often be somewhat less, although this is not necessarily the case in all instances. The multiple prostheses may be deployed individually or in groups of two or more at a single location or at multiple spaced-apart locations in the body lumen or lumens.
- In another aspect of the present invention, stent structures will comprise a plurality of radially expansible rings, as generally described above, arranged along an axial line. Expansible rings are arranged adjacent to each other and will include axially extending elements which interleave or nest with similarly axially extending elements on adjacent rings. By “interleaved” it is meant that the axially extending elements on adjacent rings will interpenetrate with each other in an axial direction, at least prior to stent expansion and preferably even after stent expansion. Usually, the interpenetrating elements will not overlap, i.e., be positioned one over another in the radial direction, but it is possible that in some implementations there may be some overlapping prior to or even after expansion. The axial interpenetration will be at least 0.1 mm, usually being at least 1 mm, and often being in the range from 1 mm to 5 mm, and will of course depend on the axial length(s) of the adjacent ring(s). Expressed as a percentage, the axial length of the axially extending elements will usually be at least 5% of the axial length of the ring, usually being from 5% to 50%, and preferably being from 20% to 30%.
- Preferably, the axially extending elements on adjacent rings will interleave without interlocking so as to permit axial separation between the adjacent rings prior to expansion of the rings. However, axially extending elements may, in some instances, also interpenetrate in a peripheral direction prior to expansion. Such peripheral interpenetration can provide axial interlocking of the axially adjacent expansible rings prior to expansion. It will usually be desirable or even necessary that the peripheral interpenetration be relieved during radial expansion of the stent structures so that the independent rings be released from each other when deployed. In other instances, however, a tether or other types of links may be provided to interconnect or otherwise restrain the rings even after expansion and deployment.
- It is not necessary that all adjacent rings be unconnected, although at least two, and preferably three, four, five, eight, ten, or more adjacent rings will be unconnected. Thus, some (but fewer than all) of the adjacent rings of the stent structures may have ties or links therebetween, including flexible or non-flexible (deflectable) ties or links. The axially adjacent rings, however, will usually not be connected, although in some cases they may have easily separable or non-permanent connections as described in more detail below. Each expansible ring will preferably comprise expansible closed cell structures, as set forth above. Less preferably, the expansible rings may comprise expansible open cell structures, as set forth above. The lengths and diameters of the individual rings have been set forth generally above. The stent structure will typically comprise from 2 to 50 individual rings, usually from 3 to 30 individual rings, and often from 3 to 25 individual rings.
- The spacing between adjacent rings may be uniform or non-uniform, preferably being uniform. In some cases, it is desirable that the edges of the adjacent rings be spaced-apart by a uniform distance in the axial direction, typically at least 0.1 mm, usually being from 0.1 mm to 0.5 mm, prior to stent expansion. In other situations, it will be preferred that the adjacent rings be in contact with each other at discreet points or along continuous sections of the edges. In some cases, the stent structures will be configured to shorten upon expansion to increase the spacing between rings. It is usually preferable that the edges of the adjacent rings not overlap, at least prior to deployment. Deployment of the stents, particularly in curved and tortuous luminal regions, may sometimes result in touching and overlapping of the stent rings.
- The stent structures may be modified in a variety of ways which are used with other conventional stents. For example, some or all of the radially expansible rings may releasably carry a biologically active agent, such as an agent which inhibits hyperplasia. Exemplary anti-hyperplasia agents include anti-neoplastic drugs, such as paclitaxel, methotrexate, and batimastal; antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin; amino suppressants such as dexamethasone and methyl prednisolone; nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like.
- In another aspect of the present invention, a stent deployment system comprises an elongate carrier having a central axis and including a plurality of radially expansible rings arranged over a surface thereof. At least some of the radially expansible rings will have the features and characteristics just described with respect to the present invention. The elongate carriers of the stent deployment systems will typically comprise a radially expansible balloon having an outer surface where the radially expansible rings are disposed over the outer surface of the balloon. In such cases, the balloon may comprise a single inflation chamber in which case all of the rings will be expanded simultaneously. Alternatively, the balloon may comprise a plurality of independently inflatable chambers so that individual expansible rings may be deployed separately from the other rings.
- The elongated carrier of the stent deployment system may alternatively comprise a carrier tube having an inner surface which carries and constrains the radially expansible rings. In such cases, the expansible rings will usually be self-expanding, i.e., held in a radially constrained configuration by the carrier tube prior to release and expansion at a luminal target site. Usually, the carrier tube structures will further comprise a pusher tube arranged to axially advance the radially expansible rings from the carrier tube. The elongated carrier may still further comprise a balloon arranged to receive and expand individual rings as they advance from the carrier tube, in which case the carrier may be used for delivering the formable (balloon-expansible) stent structures. However, such a balloon may also be used with self-expanding stent structures to control or enhance expansion, to perform predilatation of a lesion prior to stent deployment, or to further expand the stent structures and dilate the vessel lumen after the structures have self-expanded.
- In a further aspect of the present invention, multiple independent stent rings are arranged on a carrier by the following methods. An elongated carrier structure is provided and a plurality of radially expansible rings comprising axially extending elements are mounted on the carrier structure such that the axially extending elements on adjacent rings interleave or nest after they are mounted. The number of rings mounted on the carrier is selected to provide a desired overall stent length, and the number of rings is typically in the ranges set forth above, providing overall stent lengths in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm. Other aspects of the individual radially expansible rings have been described above.
- In yet another aspect of the present invention, methods for stenting a body lumen comprise delivering to the body lumen a stent structure having a plurality of radially expansible rings. The rings are as described above with respect to other aspects of the present invention, and at least some of the rings are expanded within the body lumen so that the axially extending elements open and axially move apart from each other as they radially expand. Preferably, the length of the axially extending elements and degree of radial expansion will be selected so that the elements remain interleaved even after being fully expanded within the body lumen. Such an interleaving structure enhances the continuity of lumenal wall coverage provided by the deployed stent structure. Target body lumens are typically blood vessels, more typically arteries, such as coronary arteries. The rings may be delivered simultaneously, typically using a single inflatable balloon, or sequentially, typically using a carrier tube, pusher tube and optionally deployment balloon. Methods may be used for delivering from 3 to 50 rings, usually from 3 to 30 rings, and typically from 3 to 25 rings, to cover a luminal length in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.
- FIG. 1 is a schematic illustration of a stent structure according to the present invention comprising a plurality of closed cell ring structures.
- FIG. 2 illustrates the stent structure of FIG. 1 shown in its radially expanded configuration.
- FIGS. 2A and 2B illustrate the difference in deployed configuration of non-nested and nested stent structures, respectively.
- FIG. 3 illustrates a stent structure constructed in accordance with the principles of the present invention comprising a plurality of open cell expansible rings.
- FIG. 4 illustrates the stent structure of FIG. 3 shown in its radially expanded configuration.
- FIG. 5 illustrates a first exemplary expansible ring structure in accordance with the principles of the invention.
- FIG. 6 illustrates a stent structure comprising a plurality of the ring structures of FIG. 5, shown in a rolled out radially collapsed configuration.
- FIGS. 6A and 6B illustrate variations on the ring structure of FIG. 6, where the variations are chosen to inhibit axial separation of the ring structures prior to deployment.
- FIG. 7 illustrates the stent structure of FIG. 6 shown in its radially expanded configuration.
- FIG. 8 illustrates a second exemplary expansible ring structure in accordance with the principles of the present invention.
- FIG. 9 illustrates a stent structure comprising a plurality of the rings of FIG. 8.
- FIG. 10 illustrates the stent structure of FIG. 8 in its radially expanded configuration.
- FIGS. 11-14 illustrate further exemplary expansible ring structures in accordance with the principles of the present invention.
- FIGS. 15A and 15B illustrate a further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
- FIGS. 16A and 16B illustrate a still further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
- FIGS. 17A and 17B illustrate deployment of a closed cell stent structure according to the present invention with both a balloon having a single chamber (FIG. 16) and a balloon having multiple chambers to permit selective delivery of portions of the stent structure (FIG. 17).
- FIGS. 18A-18D illustrate deployment of a plurality of a expansible rings which form a stent structure according to the present invention using a delivery tube and pusher tube in combination with an expansion balloon.
- FIG. 19 illustrates a kit constructed in accordance with the principles of the present invention.
- FIGS. 20A-20B,21A-21B, and 22A-22B illustrate further embodiments of stent structures according to the invention in unexpanded and expanded configurations.
- The present invention provides apparatus, systems, and methods for preparing and delivering stent structures comprising a plurality of “separate” or “discreet” radially expansible ring segments. By “separate” or “discreet,” it is meant that the ring segments are unconnected (or easily disconnected) at the time they are delivered to a target body lumen. Usually, the ring segments will be closely packed to provide a relatively high degree of vessel wall coverage after they are expanded. By disconnecting the adjacent segments, however, such a tightly packed structured can retain a very high degree of flexibility permitting delivery and conformance in even highly torturous regions of the vasculature and other body lumens.
- The ability to closely pack the expansible ring segments and achieve a high degree of vessel wall coverage is achieved at least partly because at least some of the axially adjacent rings comprise axially extending elements which interleave or nest with axially extending elements on an adjacent connected ring. Usually, the axially extending elements will be formed from a radially expansible portion of the ring, e.g., the element will be part of the closed cell structure or open cell structure as described in more detail hereinbelow. As these expansible sections will typically foreshorten as they are radially expanded, interleaving and nesting the segments on adjacent rings prior to expansion minimizes or preferably eliminates any gaps in coverage after the stent is expanded, as described in more detail below.
- The stent structures of the present invention may be fabricated as either balloon-expansible or self-expanding stents according to methods well known in the art. Typical deformable materials suitable for fabricating balloon-expansible stent structures include 316L stainless steel, gold, platinum, cobalt chrome, platinum, and the like. Suitable resilient materials for self-expanding stents include nickel titanium alloys, various spring stainless steel alloys, Eligloy® alloy, and the like. It will also be possible to form the stent structures of the present invention from both natural and synthetic polymers. Natural polymers include collagen, gelatin, chitin, cellulose, and the like. Suitable synthetic polymers include polyglycolic acids (PGA), polylactic acids (PLA), poly ethylene glycols (PEG), polyamides, polyimides, polyesters, and the like. In some instances, it would be possible to form different radially expansible segments from different materials in order to achieve different properties.
- The stent structures will comprise a plurality of the individual radially expansible ring segments with typical dimensions, numbers, and the like, described above in the summary. The plurality of ring segments will be arranged prior to delivery, in a manner suitable for delivery to and deployment within a target blood vessel or other body lumen. Usually, the plurality of radially expansible rings will be arranged along an axial line, typically defined by a deployment balloon, a delivery tube, or some combination thereof. The expansible ring segments will be arranged so that the axially extending elements on each of the segments is interleaved with corresponding axial extending elements on adjacent but unconnected ring segments. Referring now to FIGS. 1-4, such arrangements will be generally described for both closed cell ring structures (FIGS. 1 and 2) and open cell ring structures (FIGS. 3 and 4).
- In FIG. 1, a portion of a
stent structure 10 comprising a plurality of radially expansible rings 12 is illustrated. Each radiallyexpansible ring 12 includes a plurality of closed rhomboid ordiamond structures 14 circumferentially joined byconnectors 16. It will appreciated that thestent structure 10 is shown in a “rolled-out” configuration, and that only a portion of the structure is depicted for simplicity. Usually, the stent structure would contain a greater number ofexpansible rings 12, and each ring would include a larger number of rhomboid cells. - Of particular importance to the present invention, FIG. 1 illustrates that each
rhomboid cell 14 includes anaxially extending element 18 which interleaves with a similar element on an adjacent ring structure. This interleaved structure permits a very close packing of the rings without the need to physically attach the rings. Moreover, when the stent structure is radially expanded, as shown in FIG. 2, theaxially extending elements 18 will usually continue to axially interleave which increases the coverage of the body lumen wall being treated. - The advantages of the present invention are particularly apparent in curved blood vessels BV, as illustrated in FIGS. 2A and 2B. An expanded, non-interleaved multiple ring stent is shown in FIG. 2A. Substantial gaps G appear between the
axially extending elements 18 on the large diameter side of the curved vessel segment. In contrast, the nested stent configurations of the present invention are able to maintain interleaving of theaxially extending elements 18, even on the large diameter side of the curved vessel segment, as shown in FIG. 2B. While the present invention cannot assure that gaps will always be eliminated, the number and extent of the gaps will at least be reduced, thus improving wall coverage. - A similar result can be achieved with a
stent structure 20 comprising a plurality of open cellzigzag ring structures 22, shown in FIGS. 3 and 4. Each zigzag ring includes axially extending elements which alternate directions, and the rings are arranged so that the elements are “nested” as shown in FIG. 3. After radially expansion of thestent structure 20, the nested axially extending elements of therings 22 remain generally overlapping, as shown in FIG. 4, even when the stent has undergone significant radial expansion. While prior stent structures have utilized nested zigzag structures, they have generally either connected adjacent structures or utilized only a single filament for forming such structures. In neither case can the flexibility achieved by the present invention in combination with the ability to selectively deliver independent radially expansible segments be achieved. - Referring now to FIGS. 5-7, a
particular stent structure 30 comprising a plurality of radially expansible rings 32 is illustrated. Eachring 32, as shown in FIG. 5, comprises a plurality ofclosed cell boxes 34 joined at their midpoints by circumferentially directedconnectors 36. Eachbox 34 includes acentral opening 35 which is generally an axial cut enlarged at each end and in the middle. As with prior illustrations, thering structure 32 is shown in its rolled-out or flattened configurations. In the actual stent structure, the ring would be rolled so that the “broken”connectors 34′ are in fact connected to form a cylindrical shape. The “bow tie” shape of thecentral opening 35 is advantageous as it permits maximum radial compression of the stent while minimizing both the delivery profile and the stress relief of the stent during expansion in the body lumen. - FIG. 6 illustrates the very tight packing of the
stent structure 30 that can be achieved. Thestent structure 30 in FIG. 6 is in its pre-deployment configuration as it would be when placed over a balloon or within a delivery tube, as described in more detail hereinbelow. It can be seen that virtually all of the available area for carrying the stent is covered. Thus, when the stent is expanded as shown in FIG. 7, the area of the blood vessel or other luminal wall will be maximized. Moreover, this very close packing of the stent is achieved while concurrently providing a very high degree of flexibility while the stent is being delivered and conformability after the stent is deployed. Such flexibility results in large part from the fact that the adjacent rings are unconnected and free to move relative to each other as the stent is delivered and deployed. Coverage in curved vessels will be improved with the specific design of FIGS. 6 and 7 generally as shown in FIGS. 2A and 2B. - Axial separation of the
rings 32 ofstent structure 30 can be inhibited by modifying the ring geometries in a variety of ways, such as shown in FIGS. 6A and 6B. In FIG. 6A, the boxes 34 a are fabricated (or deformed after fabrication) to collapse near the centers so that they form “bow tie” structures, with enlarged ends 34 b interlocking. Alternatively, the boxes 34 c can be inclined relative to the axial direction, as shown in FIG. 6B, to also provide interlocking of adjacent rings prior to deployment. Such inclination can be used with at least most of the embodiments of the present invention to improve axial retention. In addition, other patterns, such as chevrons, interleaved sigmoidal shapes, and the like could also be used to provide the desired interlocking prior to stent expansion. - Referring now to FIGS. 8-10, a similar degree of wall coverage and flexibility can be achieved with open cell stent structures. Stent structure40 (FIG. 9) comprises a plurality of open cell expansible rings 42 formed in a “castellated” pattern, as shown in more detail in FIG. 8. The castellations comprise narrow
U-shaped loops circumferential center line 48. Therings 42 are arranged so that theloops loops - Referring now to FIGS. 11-14, additional embodiments of the radially expansible ring segments are illustrated. As with prior illustrations, the ring segments are shown in their pre-deployed configuration in a rolled-out manner.
Ring structure 50 of FIG. 11 comprises a plurality of closedcell box elements 52 joined bycircumferential connectors Ring 50 is similar to ring 32 of FIG. 5, except that thecircumferential connectors 54 are split to form H-shapedslots 55 which span pairs ofadjacent box structures 52 and theintermediate connectors 54 form a single, larger cell structures. Such larger openings are advantageous when stenting in blood vessels with side branches which must be kept open. In particular, the side branches may be accessed by opening theslots 55 with a balloon structure. In contrast, the cell pattern of stent 32 (FIG. 5) provides a greater coverage that may be of particular importance with drug eluting stents. - Stent structures comprising
multiple rings 50 are shown in their unexpanded and expanded configuration in FIGS. 1A and 11B, respectively. Of particular note, the open slots 55 (FIG. 11B) provide for significant additional expansion (via balloon dilation or other subsequent intervention) in order to provide access to a side branch or for any other purpose. A further expandedslot 55 is shown in FIG. 11C, as expanded by balloon B. -
Ring structure 60 of FIG. 12 comprises a plurality ofinterconnected box structures box structures rings 60.Axially extending elements -
Ring structure 70 in FIG. 13 comprises paired,symmetric box structures circumferential connectors 76. Each of thebox structures rings 70. This particular structure will provide good adherence to an expandable delivery balloon during deployment and have many of the same advantages as the embodiment of FIG. 12. -
Ring structure 80 of FIG. 14 is similar to that ofring structure 70 of FIG. 13, except that the “longer” rings terminate in a retainer, such as T-ends 82. When deployingmultiple rings 80 in a stent structure, the T-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and,adjacent ring segments 80 will naturally release from each other during deployment. Moreover, since the interlocking structures are not actually attached, they permit a high degree of flexibility while the stent is being deployed. While T-ends are shown in FIG. 14, the terminal retainers could be L- or J-shaped ends or have any other geometry, which also provides for interlocking. In particular, each of these geometries will include a peripherally extendingsegment 83 which interlocks with a peripherally extendingsegment 83 on an adjacent T-end 82. Upon expansion of thering 80, thesegment 83 will move apart allowing the adjacent rings to deploy separately. When deployingmultiple rings 80 in a stent structure, the T-, L- or J-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and,adjacent ring segments 80 will naturally release from each other during deployment. Such interlocking could also incorporated in the embodiments of FIGS. 5, 8, 11 and 12. - As illustrated thus far, the stent structures have generally maximized to vessel wall coverage achieved after expansion. While this will often be desired, in some instances it may be desired to lessen the amount of wall coverage. The stent structures shown in FIGS. 15A and 15B and FIGS. 16A and 16B, achieve such reduced wall coverage by providing “spacers” between adjacent rings.
- In FIG. 15A, a
stent structure 90 includesindependent rings 92 havingboxes 93 circumferentially separated byspacers 94. Thespacers 94 will either not expand or expand only after theboxes 93 have expanded, thus maintaining an axial distance D between adjacent rings after expansion, as shown in FIG. 15B. The distance D will be equal to about one-half the total axial length of thespacer 94. - Stent structure96 (FIGS. 16A and 16B) is similar to
structure 90, except thatspaces 97 are axially split to define an H-shaped cell (as discussed with earlier embodiments) and certain of therings 98 and joined bysigmoidal links 99. - Stent structures according to the present invention may be delivered in a variety of ways. As illustrated in FIGS. 17A-17C, the
stent structure 30 may be delivered on aballoon catheter 90 having aballoon 92 with a single inflation chamber. Deployment of thestent 30 is illustrated in FIG. 17B where allindependent ring structures 32 are expanded simultaneously. Alternatively, as illustrated in FIG. 17C, catheter may carry aballoon 94 having a plurality of independently inflatable compartments. In that way, one or more of the independent compartments may be inflated separately from others of the compartments to selectively deploy one, two, three, or more of theindependent ring structures 32. In that case, others of thering structures 32 will remain unexpanded and available for separate expansion or may be simply removed from the patient if unused. - Referring now to FIGS. 18A-18D, an alternative stent structure delivery protocol employing a carrier tube will be described. Such delivery protocols are described in more detail in co-pending application Ser. No. 10/306,813, filed on Nov. 27, 2002 (Attorney Docket Number 021629-000320US), and in copending application Ser. No. 10/637,713, filed Aug. 8, 2003 (Attorney Docket No. 21629-000340US), the full disclosures of which are incorporated herein by reference. Catheter160 (FIG. 18A) comprises a
sheath 164,pusher tube 166, and acatheter body 168. Thecatheter body 168 includes anexpansible balloon 170 over its distal portion. Individual expansible rings, as described above, are deployed, as illustrated in FIGS. 18B and 18C, by first advancing thedistal-most ring 162 using thepusher tube 166. Thecatheter body 168 is also distally advanced so that a distal portion of theballoon 170 lies within the distal-most deployedring 162, as shown in FIG. 18B. The remaining proximal portion of theballoon 170 will, of course, remain within theother rings 162 which themselves remain within thesheath 164. Theballoon 170 is then inflated, but only the advanced distal portion of the balloon inflates within theadvanced ring 162, as illustrated in FIG. 18C. Expansion of the remaining proximal portion of the balloon is prevented by thesheath 164. Similarly, the remainingrings 162 remain unexpanded since they remain within thesheath 164. - Referring now to FIG. 18D,
additional rings 162 may be deployed, either at the same target location within the blood vessel or at a different, spaced-apart locations within the blood vessel. Deployment of tworings 162 is illustrated. The tworings 162 are axially advanced using thepusher tube 162 so that they are positioned over theuninflated balloon 170. Theballoon 170 is then inflated, as illustrated in FIG. 18D, thus expanding therings 162 within the blood vessel BV. It will be appreciated that thecatheter 160 could carry many more than the four illustratedrings 162, and three, four, five, ten, and even 20 or more individual rings could be deployed at one time, with additional single prostheses or groups of prostheses being deployed at different times and/or at different locations within the blood vessel. The use of “stent valves” as described in application Ser. No. 10/306,813, previously incorporated herein by reference, may preferably be employed to facilitate controlling the number of rings deployed and the spacing between the deployed and undeployed rings. - Referring now to FIG. 13,
kits 200 according to the present invention comprise a catheter 160 (or a balloon catheter) in combination with instructions for use IFU. The instructions for use set forth any of the methods of the present invention, and in particular set forth how thecatheter 160 may be used to implant a stent structure comprising multiple rings within a blood vessel or other body lumen. Thecatheter 160 and instructions for use will typically be packaged together, for example within aconventional package 202, such as a box, tube, pouch, tray, or the like.Catheter 160 will typically be maintained in a sterile condition within thepackage 202. The instructions for use may be provided on a package insert, may be printed in whole or in part on the packaging, or may be provided in other ways, such as electronically over the internet, on an electronic medium, such as a CD, DVD, or the like. - A further alternative stent structure according to the invention is illustrated in FIGS. 20A-20B. FIG. 20A illustrates a portion of a
stent segment 201 in an unexpanded configuration, shown in a planar shape for clarity.Stent segment 201 comprises twoparallel rows cells 205 formed around an axis A so thatstent segment 201 has a cylindrical shape. The terms “I-shaped” and “H-shaped” as used herein may refer to a similar cell geometry comprising two generally parallel slots connected by an interconnecting slot. Such cells may appear H-shaped when axis A is in a vertical orientation, or I-shaped axis A is in a horizontal orientation. Eachcell 205 has upper and loweraxial slots 207 aligned with the axial direction and acircumferential slot 204. Upper andlower slots 207 preferably have an oval, racetrack, rectangular or other oblong shape with a long dimension L generally parallel to axis A and a short dimension W perpendicular thereto.Axial slots 207 are bounded by upperaxial struts 206A and loweraxial struts 206B, curved outer ends 208 and curved inner ends 210. Eachcircumferential slot 204 is bounded by an outercircumferential strut 209 and an innercircumferential strut 211. Each I-shapedcell 205 is connected to the adjacent I-shapedcell 205 in the same row 98A or 98B by acircumferential connecting strut 213. All or a portion ofcells 205 in row 98A merge or join withcells 205 in row 98B at the inner ends 210, which are integrally formed with the inner ends 210 of theadjacent cells 205. -
Stent segment 201 is configured to interleave with an adjacent stent segment of similar construction. Upper and loweraxial struts outer ends 208 form axial elements E that are received in the spaces S between each element E of theadjacent stent segment 201. - In a preferred embodiment, a spacing
member 212 extends outwardly in the axial direction from a selected number of outer circumferential struts 209 and/or connectingstruts 213. Spacingmember 212 preferably itself forms asubcell 214 in its interior, but alternatively may be solid without any cell or opening therein. For those spacingmembers 212 attached to outer circumferential struts 209,subcell 214 preferably communicates with I-shapedcell 205. Spacingmembers 212 are configured to engage the curved outer ends 208 of anadjacent stent segment 201 so as to maintain appropriate spacing between adjacent stent segments. In one embodiment, spacingmembers 212 haveouter ends 216 with two spaced-apart protrusions 218 that provide a cradle-like structure to index and stabilize the curvedouter end 208 of the adjacent stent segment. Preferably, spacingmembers 212 have an axial length of at least about 10%, more preferably at least about 25%, of the long dimension L of I-shapedcells 205, so that the I-shapedcells 205 of adjacent stent segments are spaced apart at least that distance. This results in elements E interleaving a distance of at least about 10%, preferably at least about 25%, and more preferably at least about 50% of their axial length as measured from the circumferential connectingstruts 213. Because spacingmembers 212 experience little or no axial shortening during expansion ofstent segments 201, this minimum spacing between stent segments is maintained both in the unexpanded and expanded configurations. - FIG. 20B shows
stent segment 201 of FIG. 20A in an expanded configuration. It may be seen thatcells 205 are expanded so that upper andlower slots 207 are diamond shaped withcircumferential slots 204 remaining basically unchanged. This results in some axial shortening of the stent segment, thereby increasing the spacing between adjacent stent segments. The stent geometry is optimized by balancing the amount of axial shortening and associated inter-segment spacing, the desired degree of vessel wall coverage, the desired metal density, and other factors. Because the stent is comprised of multipleunconnected stent segments 201, any desired number from 2 up to 10 or more stent segments may be deployed simultaneously to treat lesions of any length from 2 mm up to 100 mm or more. Further, because such segments are unconnected to each other, the deployed stent structure is highly flexible and capable of deployment in long lesions having curves and other complex shapes. - As an additional feature,
circumferential slots 204 provide a pathway through which vessel side branches can be accessed for catheter interventions. Shouldstent segment 201 be deployed at a location in which it covers the ostium of a side branch to which access is desired, a balloon dilatation catheter may be positioned throughcircumferential slot 204 and expanded. This deformscircumferential struts circumferential slot 204 and further expanding upper andlower slots 207, as shown in phantom in FIG. 20B. This provides a relativelylarge opening 220 through which a catheter may be inserted throughstent segment 201 and into the side branch for placing stents, performing angioplasty, or carrying out other interventions. - FIGS. 21A-21B illustrate a second embodiment of a
stent segment 201′ according to the invention. In FIG. 21A, twostent segments 201′ are shown interleaved in a planar shape for clarity. Similar to the embodiment of FIG. 20A,stent segment 201′ comprises twoparallel rows cells 224 formed into a cylindrical shape around axialaxis A. Cells 224 have upper and loweraxial slots 226 and a connectingcircumferential slot 228. Upper and loweraxial slots 226 are bounded by upperaxial struts 230, loweraxial struts 232, curved outer ends 234, and curved inner ends 236, forming axial elements E configured to be received in spaces S between elements E in theadjacent stent segment 201′.Circumferential slots 228 are bounded by an outercircumferential strut 238 and innercircumferential strut 240. Each I-shapedcell 224 is connected to the adjacent I-shapedcell 224 in the same row 222 by acircumferential connecting strut 242.Row 222A is connected to row 222B by the merger or joining of curved inner ends 236 of at least one and preferably two ofslots 226 in each row 222. - One of the differences between the embodiment of FIGS. 21A-21B and that of FIGS. 20A-20B is the way in which spacing is maintained between the adjacent interleaved stent segments. In place of the
spacing members 212 of the earlier embodiment, the embodiment of FIG. 21A includes abulge 244 in upper and loweraxial struts axial slots 226. These giveaxial slots 226 an arrowhead or cross shape at their inner and outer ends. Thebulge 244 in each upperaxial strut 230 extends toward thebulge 244 in a loweraxial strut 232 in thesame cell 205 or in anadjacent cell 205, thus narrowing the space S therebetween and creating aconcave abutment 246 in the space between eachaxial slot 226.Concave abutments 246 are configured to receive and engage curved outer ends 234 ofcells 224 in the adjacent stent segment, thereby maintaining spacing between the stent segments. The axial location ofbulges 244 along upper and loweraxial struts concave abutments 246 from curved outer ends 234 is at least about 10% of the axial length of elements E (measured from circumferential struts 242), preferably at least about 25% of the axial length of elements E, and more preferably at least about 50% of the axial length of elements E. - FIG. 21B shows two
stent segments 201 of FIG. 21A in an expanded condition. It may be seen thataxial slots 226 are deformed into a circumferentially-widened modified diamond shape withbulges 244 on the now diagonal upper and loweraxial struts Circumferential slots 228 are generally the same size and shape as in the unexpanded configuration.Bulges 244 have been pulled away from each other to some extent, but still provide aconcave abutment 246 to maintain a minimum degree of spacing between adjacent stent segments. As in the earlier embodiment, some axial shortening of each segment occurs upon expansion and stent geometry can be optimized to provide the ideal intersegment spacing. - In a preferred embodiment,
stent segments 201′ retain some degree of interleaving in the expanded configuration, withouter ends 234 of elements E on adjacent stent segments being at least circumferentially aligned with each other, and preferably extending into spaces S of the adjacent stent segment a distance of at least about 1%, more preferably at least about 5%, and in some cases at least about 10% of the axial length of elements E as measured from circumferential connectingstruts 242. In one exemplary embodiment, for astent segment 201′ having an axial length of 4 mm and an unexpanded diameter of about 0.5-1.5 mm, elements E have an axial length of about 1 mm and are interleaved a distance Du of about 0.1-0.5 mm in the unexpanded configuration.Segments 201′ are expandable to a diameter of 2.5-3.5 mm and elements E are interleaved a distance De of about 0.01-0.1 mm in the expanded configuration. - It should also be noted that the embodiment of FIGS. 21A-21B retains the feature described above with respect to FIGS. 20A-20B to enable access to vessel side branches blocked by
stent segment 201′. Should such side branch access be desired, a dilatation catheter may be inserted intocircumferential slot 228 and expanded to provide an enlarged opening through which a side branch may be entered. - FIGS. 22A-22B illustrate a variant of the stent structure of FIGS. 21A-21B that has a larger expanded diameter. The primary difference in the embodiment of FIGS. 22A-22B is the geometry of the inner ends236′ of each
axial slot 226′. Rather than being curved, inner ends 236′ are generally straight and oriented in the circumferential direction. Because of the longer circumferential dimension of the inner ends 236′, aninner portion 250 of eachaxial strut 230′, 232′ is disposed at an angle relative to the axial direction, giving theinner half 252 of eachaxial slot 226′a trapezoidal shape. Again, bulges 244′ are disposed alongaxial struts 230′, 232′ so as to createconcave abutments 246′ that engage the outer ends 234′ ofaxial slots 226′ and maintain inter-segment spacing. - As shown in FIG. 22B,
stent segment 201″ expands to a configuration similar to that of FIG. 21B, with the exception that inner ends 236′ remain generally straight and aligned with the circumferential direction.Axial slots 226′ are again expanded into a modified diamond shape, withbulges 244′ extending into spaces S to maintain inter-segment spacing. In an exemplary embodiment,stent segment 201″ has a length of about 4 mm and diameter of about 1.0-2.0 mm when unexpanded, and is expandable to a diameter of about 3.0-4.0 mm. - The stent structures of the invention are preferably radiopaque so as to be visible by means of fluoroscopy. Radiopaque markers and/or materials may be used in or on the stent structures. Markers of radiopaque materials may be applied to the exterior of the stents, e.g, by applying a metal such as gold, platinum, a radiopaque polymer, or other suitable coating or mark on all or a portion of the stents. Alternatively, the stent structures may include a radiopaque cladding or coating or may be composed of radiopaque materials such as MP35N (ASTM562), L-605 cobalt chromium (ASTM F90), other suitable alloys containing radiopaque elements, or multilayered materials having radiopaque layers. As a further option, the stent structures may have a geometry conducive to fluoroscopic visualization, such as having struts of greater thickness, sections of higher density, or overlapping struts. Some of the possible materials that may be used in the stent segments, either alone or in combination, include (by ASTM number):
- F67-00 Unalloyed Titanium
- F75-01 Cobalt-28 Chromium-6 Molybdenum Alloy
- F90-01 Wrought Cobalt-20 Chromium-15 Tungsten-10 Nickel Alloy
- F136-02a Wrought Titanium-6 Aluminum-4 Vanadium ELI Alloy
- F138-00, F139-00 Wrought 18 Chromium-14 Nickel-2.5 Molybdenum Stainless Steel Bar or Sheet
- F560-98 Unalloyed Tantalum
- F562-02 Wrought 35 Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy
- F563-00 Wrought Cobalt-20 Nickel-20 Chromium 3.5 Molybdenum-3.5 Tungste-5 Iron Alloy
- F688 Wrought Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy
- F745-00 18 Chromium-12.5 Nickel-2.5 Molybdenum Stainless Steel
- F799-02 Cobalt-28 Chromium-6 Molybdenum Alloy
- F961-96 Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy
- F1058-02 Wrought 40 Cobalt-20 Chromium-16 Iron-15 Nickel-7 Molybdenum Alloy
- F1091-02 Wrought Cobalt-20 Chromium-15 Tungsten-10 Nickel Alloy
- F1108 Titanium-6 Aluminum-4 Vanadium Alloy
- F1295-01 Wrought Titanium-6 Aluminum-7 Niobium Alloy
- F1314-01 Wrought Nitrogen-strengthened 22 Chromium-13 Nickel-5 Manganese-2.5 Molybdenum Stainless Steel Alloy
- F1241-99 Unalloyed Titanium Wire
- F1350-02 Wrought 18 Chromium-14 Nickel-2.5 Molybdenum Stainless Steel Wire
- F1377-98a Cobalt-28 Chromium-6 Molybdenum Powder coating
- F1472-02 a Wrought Titanium-6 Aluminum-4 Vanadium Alloy
- F1537-00 Wrought Cobalt-28 Chromium-6 Molybdenum Alloy
- F1580-01 Titanium and Titanium-6 Aluminum-4 Vanadium Alloy Powder coating
- F1586-02 Wrought Nitrogen Strengthened 21 Chromium-10 Nickel-3 Mnaganese-2.5 Molybdenum Stainless Steel Bar
- F1713-96 Wrought Titanium-13 Niobium-13 Zirconium Alloy
- F1813-01 Wrought Titanium-12 Molybdenum-6 Zirconium-2 Iron Alloy
- F2063-00 Wrought Nickel-Titanium Shape Memory Alloys
- F2066-01 Wrought Titanium-15 Molybdenum Alloy
- F2146-01 Wrought Titanium-3 Aluminum-2.5 Vanadium Alloy Seamless Tubing
- F2181-02a Wrought Stainless Steel Tubing
- The preferred embodiments of the invention are described above in detail for the purpose of setting forth a complete disclosure and for the sake of explanation and clarity. Those skilled in the art will envision other modifications within the scope and sprit of the present disclosure.
Claims (76)
1. A stent structure comprising:
a plurality of radially expansible rings arranged along an axial line, wherein at least some of the axially adjacent rings are not connected and wherein at least some of the axially unconnected rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent unconnected ring.
2. A stent structure as in claim 1 , wherein at least some of the axially extending elements comprise expansible closed structures which open as the rings are expanded.
3. A stent structure as in claim 2 , wherein the expansible closed structures are selected from the group consisting of boxes, diamonds, rhomboids, ovals, and ellipses.
4. A stent structure as in claim 2 , wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns, H-patterns, and J-patterns.
5. A stent structure as in claim 1 , wherein at least some of the axially extending elements comprise expansible open structures.
6. A stent structure as in claim 5 , wherein the expansible open structures are selected from the group consisting of serpentine structures, zigzag structures, and castellated structures.
7. A stent structure as in claim 1 , wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
8. A stent structure as in claim 1 , wherein the axially unconnected rings are configured to axially shorten upon expansion.
9. A stent structure as in claim 1 , wherein the axially extending elements remain interleaved following expansion.
10. A stent structure as in claim 1 , wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
11. A stent structure as in claim 10 , wherein the distance is in the range from 1 mm to 5 mm.
12. A stent structure as in claim 1 , wherein the rings have axial lengths in range from 1 mm to 10 mm, prior to radial expansion.
13. A stent structure as in claim 1 , consisting of from two to 50 expansible ring structures.
14. A stent structure as in claim 1 , wherein the radially expansible rings releasably carry a biologically active agent.
15. A stent structure as in claim 14 , wherein the biologically active agent inhibits hyperplasia.
16. A stent structure as in claim 15 , wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs, including paclitaxel, methotrexate, and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone, and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
17. A stent deployment system comprising:
an elongated carrier having a central axis;
a plurality of radially expansible rings arranged over a surface of the elongated carrier, wherein at least some of the radially expansible rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent radially expansible ring.
18. A stent deployment system as in claim 17 , wherein the elongated carrier comprises a radially expansible balloon having an outer surface, wherein the radially expansible rings are disposed over the outer surface of the balloon.
19. A stent deployment system as in claim 18 , wherein the balloon consists of a single inflation chamber.
20. A stent deployment system as in claim 18 , wherein the balloon comprises a plurality of independent chambers wherein individual expansible rings are disposed over single independently inflatable chambers.
21. A stent deployment system as in claim 17 , wherein the elongated carrier comprises a carrier tube having an inner surface which constrains the radially expansible rings.
22. A stent deployment system as in claim 21 , further comprising a pusher tube arranged to axially advance the radially expansible rings from the carrier tube.
23. A stent deployment system as in claim 22 , wherein the radially expansible rings are resilient and radially constrained so that they expand when advanced distally from the carrier tube.
24. A stent deployment system as in claim 17 , wherein the radially expansible rings are deformable, said structure further comprising a balloon arranged to expand individual rings as said rings are advanced from the carrier tube.
25. A stent deployment system as in claim 17 , wherein at least some of the axially expanding elements comprise expansible closed structures.
26. A stent deployment system as in claim 25 , wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
27. A stent deployment structure as in claim 25 , wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns and H-patterns.
28. A stent deployment structure as in claim 17 , wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
29. A stent deployment system as in claim 17 , wherein at least some of the axially extending elements comprise expansible open structures.
30. A stent deployment system as in claim 29 , wherein the expansible open structures are selected from the group consisting of expansible structures, zigzag structures, and castellated structures.
31. A stent deployment structure as in claim 17 , wherein the radially expansible rings are configured to axially shorten upon expansion.
32. A stent deployment structure as in claim 17 , wherein the axially extending elements remain interleaved following expansion.
33. A stent deployment structure as in claim 17 , wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
34. A stent deployment structure as in claim 33 , wherein the distance is in the range from 1 mm to 5 mm.
35. A stent deployment system as in claim 17 , wherein the rings have axial lengths in range from 11 mm to 10 mm, prior to radial expansion.
36. A stent deployment system as in claim 35 , consisting of from two to 50 expansible ring structures.
37. A stent deployment system as in claim 17 , wherein the radially expansible rings releasably carry a biologically active agent.
38. A stent deployment system as in claim 37 , wherein the biologically active agent inhibits hyperplasia.
39. A stent deployment system as in claim 38 , wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate, and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
40. A method for arranging multiple independent stent rings on a carrier of a catheter, said method comprising:
providing an elongated carrier structure;
mounting a plurality of radially expansible rings comprising axially extending elements on the carrier structure, wherein the axially extending elements on adjacent rings interleave when mounted on the carrier structure without interlocking.
41. A method as in claim 40 , wherein the number of rings mounted on the carrier structure is selected to provide a desired overall stent length.
42. A method as in claim 41 , wherein the number of rings is from two to 50 and the overall stent length is in the range from 2 mm to 200 mm.
43. A method as in claim 40 , wherein at least some of the axially extending elements comprise expansible closed structures.
44. A method as in claim 43 , wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
45. A method as in claim 43 , wherein the expansible closed structures are defined by a slot pattern selected from the group consisting of I-patterns and H-patterns, and J-patterns.
46. A method as in claim 40 , wherein at least some of the axially extending elements comprise expansible open structures.
47. A method as in claim 46 , wherein the expansible open structures are selected from the group consisting of serpentine structures, zigzag structures, and castellated structures.
48. A method as in claim 40 , wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
49. A method as in claim 40 , wherein the radially expansible rings are configured to axially shorten upon expansion.
50. A method as in claim 40 , wherein the axially extending elements remain interleaved following expansion.
51. A method as in claim 40 , wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
52. A method as in claim 51 , wherein the distance is in the range from 1 mm to 5 mm.
53. A method as in claim 40 , wherein the rings have axial lengths in range from 1 mm to 10 mm, prior to radial expansion.
54. A method as in claim 53 , wherein the rings have axial lengths in the range from 0.9 mm to 9 mm after radial expansion.
55. A method as in claim 54 , consisting of from two to 50 expansible ring structures.
56. A method as in claim 40 , wherein the radially expansible rings releasably carry a biologically active agent.
57. A method as in claim 56 , wherein the biologically active agent inhibits hyperplasia.
58. A method as in claim 57 , wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
59. A method for stenting a body lumen, said method comprising:
delivering to the body lumen a stent structure having a plurality of radially expansible rings arranged along an axial line, wherein at least some of the axially adjacent rings are not connected and wherein at least some of the axially unconnected rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent unconnected ring; and
expanding at least some of the rings within the body lumen so that the axially extending elements open and axially move apart from each other.
60. A method as in claim 59 , wherein the body lumen is a blood vessel.
61. A method as in claim 60 , wherein the blood vessel is an artery.
62. A method as in claim 59 , wherein two to 50 rings are delivered over a luminal length in the range from 2 mm to 200 mm.
63. A method as in claim 59 , wherein at least some of the axially extending elements comprise expansible closed structures which circumferentially expand as the rings are expanded.
64. A method as in claim 63 , wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
65. A method as in claim 63 , wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns, H-patterns, and J-patterns.
66. A method as in claim 59 , wherein at least some of the axially extending elements comprise expansible open structures which circumferentially expand as the rings are expanded.
67. A method as in claim 66 , wherein the expansible open structures are selected from the group consisting of serpentine structure, zigzag structures, and castellated structures.
68. A method as in claim 59 , wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
69. A method as in claim 59 , wherein the axially extending elements remain interleaved following expansion.
70. A method as in claim 59 wherein the radially expansible rings are configured to axially shorten upon expansion.
71. A method as in claim 59 , wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
72. A method as in claim 71 , wherein the distance is in the range from 1 mm to 5 mm.
73. A method as in claim 59 , wherein the radially expansible rings carry a biologically active agent which is released in the body lumen after the rings are expanded.
74. A method as in claim 73 , wherein the biologically active agent inhibits hyperplasia.
75. A method as in claim 74 , wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone;
nitric oxide sources including nitroprussides; estrogen; and estradiols.
76. A method as in claim 59 , wherein the body lumen is curved, and wherein the axially extending members remain interleaved after expansion of the stent is performed.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/738,666 US20040186551A1 (en) | 2003-01-17 | 2003-12-16 | Multiple independent nested stent structures and methods for their preparation and deployment |
US10/814,593 US8080048B2 (en) | 2001-12-03 | 2004-03-30 | Stent delivery for bifurcated vessels |
US12/061,951 US20080208318A1 (en) | 2003-01-17 | 2008-04-03 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/109,477 US20080208311A1 (en) | 2003-01-17 | 2008-04-25 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/492,828 US8282680B2 (en) | 2003-01-17 | 2009-06-26 | Multiple independent nested stent structures and methods for their preparation and deployment |
US13/599,957 US8740968B2 (en) | 2003-01-17 | 2012-08-30 | Multiple independent nested stent structures and methods for their preparation and deployment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44083903P | 2003-01-17 | 2003-01-17 | |
US10/738,666 US20040186551A1 (en) | 2003-01-17 | 2003-12-16 | Multiple independent nested stent structures and methods for their preparation and deployment |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/814,593 Continuation-In-Part US8080048B2 (en) | 2001-12-03 | 2004-03-30 | Stent delivery for bifurcated vessels |
US12/061,951 Continuation US20080208318A1 (en) | 2003-01-17 | 2008-04-03 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/109,477 Continuation US20080208311A1 (en) | 2003-01-17 | 2008-04-25 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/492,828 Continuation US8282680B2 (en) | 2003-01-17 | 2009-06-26 | Multiple independent nested stent structures and methods for their preparation and deployment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040186551A1 true US20040186551A1 (en) | 2004-09-23 |
Family
ID=32994184
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/738,666 Abandoned US20040186551A1 (en) | 2001-12-03 | 2003-12-16 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/061,951 Abandoned US20080208318A1 (en) | 2003-01-17 | 2008-04-03 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/109,477 Abandoned US20080208311A1 (en) | 2003-01-17 | 2008-04-25 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/492,828 Expired - Lifetime US8282680B2 (en) | 2003-01-17 | 2009-06-26 | Multiple independent nested stent structures and methods for their preparation and deployment |
US13/599,957 Expired - Fee Related US8740968B2 (en) | 2003-01-17 | 2012-08-30 | Multiple independent nested stent structures and methods for their preparation and deployment |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/061,951 Abandoned US20080208318A1 (en) | 2003-01-17 | 2008-04-03 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/109,477 Abandoned US20080208311A1 (en) | 2003-01-17 | 2008-04-25 | Multiple independent nested stent structures and methods for their preparation and deployment |
US12/492,828 Expired - Lifetime US8282680B2 (en) | 2003-01-17 | 2009-06-26 | Multiple independent nested stent structures and methods for their preparation and deployment |
US13/599,957 Expired - Fee Related US8740968B2 (en) | 2003-01-17 | 2012-08-30 | Multiple independent nested stent structures and methods for their preparation and deployment |
Country Status (1)
Country | Link |
---|---|
US (5) | US20040186551A1 (en) |
Cited By (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130683A1 (en) * | 2001-12-03 | 2003-07-10 | Xtent, Inc., | Apparatus and methods for delivering coiled prostheses |
US20050017540A1 (en) * | 2003-07-22 | 2005-01-27 | Leigh Arthur Donald | Caravan |
US20050085897A1 (en) * | 2003-10-17 | 2005-04-21 | Craig Bonsignore | Stent design having independent stent segments which uncouple upon deployment |
WO2006005082A2 (en) | 2004-06-28 | 2006-01-12 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
WO2006036939A2 (en) | 2004-09-27 | 2006-04-06 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US20060271151A1 (en) * | 2005-05-31 | 2006-11-30 | Xtent, Inc. | In situ stent formation |
EP1749545A2 (en) * | 2005-07-29 | 2007-02-07 | Cordis Corporation | System for treating aneurysmal disease |
EP1769779A2 (en) * | 2005-09-28 | 2007-04-04 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
US20070100424A1 (en) * | 2001-12-03 | 2007-05-03 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US20070213810A1 (en) * | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
US20070233270A1 (en) * | 2006-03-29 | 2007-10-04 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
US20070239257A1 (en) * | 2006-03-29 | 2007-10-11 | Jan Weber | Stent with overlap and high extension |
WO2007143609A2 (en) | 2006-06-02 | 2007-12-13 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US20070288183A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Analog signal transition detector |
US20070288077A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Self-anchoring electrical lead with multiple electrodes |
US20070288076A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Biological tissue stimulator with flexible electrode carrier |
WO2008103741A1 (en) | 2007-02-20 | 2008-08-28 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US20090024205A1 (en) * | 2007-07-19 | 2009-01-22 | Bay Street Medical | Radially Expandable Stent |
US20090157159A1 (en) * | 2007-12-12 | 2009-06-18 | Peter Schneider | Device and method for tacking plaque to blood vessel wall |
US20090171449A1 (en) * | 2008-01-02 | 2009-07-02 | Yunbing Wang | Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles |
US20090240270A1 (en) * | 2008-03-21 | 2009-09-24 | Peter Schneider | Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque |
US20100010622A1 (en) * | 2006-03-13 | 2010-01-14 | Abbott Laboratories | Hybrid segmented endoprosthesis |
US20100042121A1 (en) * | 2008-03-21 | 2010-02-18 | Peter Schneider | Pre-angioplasty serration of atherosclerotic plaque enabling low-pressure balloon angioplasty and avoidance of stenting |
US7704275B2 (en) | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
US20100114294A1 (en) * | 2008-11-06 | 2010-05-06 | William Cook Europe Aps | Stent Member |
US7722662B2 (en) | 1998-02-17 | 2010-05-25 | Reva Medical, Inc. | Expandable stent with sliding and locking radial elements |
US7763065B2 (en) | 2004-07-21 | 2010-07-27 | Reva Medical, Inc. | Balloon expandable crush-recoverable stent device |
US20100262225A1 (en) * | 2007-12-12 | 2010-10-14 | Peter Schneider | Device and method for tacking plaque to a blood vessel wall |
US20100274114A1 (en) * | 2007-06-07 | 2010-10-28 | Denker Stephen T | Signal sensing in an implanted apparatus with an internal reference |
WO2010129846A1 (en) * | 2009-05-08 | 2010-11-11 | Synthes Usa, Llc | Expandable bone implant |
US7837726B2 (en) | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7892274B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US20110046737A1 (en) * | 2009-08-19 | 2011-02-24 | Jacques Teisen | Method and apparatus for augmenting bone |
US7914574B2 (en) | 2005-08-02 | 2011-03-29 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US7918881B2 (en) | 2003-06-09 | 2011-04-05 | Xtent, Inc. | Stent deployment systems and methods |
US7922755B2 (en) | 2001-12-03 | 2011-04-12 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7938852B2 (en) | 2001-12-03 | 2011-05-10 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7947071B2 (en) | 2008-10-10 | 2011-05-24 | Reva Medical, Inc. | Expandable slide and lock stent |
US7988721B2 (en) | 2007-11-30 | 2011-08-02 | Reva Medical, Inc. | Axially-radially nested expandable device |
US8016870B2 (en) | 2001-12-03 | 2011-09-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US20110230954A1 (en) * | 2009-06-11 | 2011-09-22 | Peter Schneider | Stent device having focal elevating elements for minimal surface area contact with lumen walls |
US8080048B2 (en) | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US8083788B2 (en) | 2001-12-03 | 2011-12-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US8142487B2 (en) | 2001-03-29 | 2012-03-27 | Xtent, Inc. | Balloon catheter for multiple adjustable stent deployment |
US20120102708A1 (en) * | 2005-02-25 | 2012-05-03 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis and methods of use |
US8177831B2 (en) | 2001-12-03 | 2012-05-15 | Xtent, Inc. | Stent delivery apparatus and method |
US8257427B2 (en) | 2001-09-11 | 2012-09-04 | J.W. Medical Systems, Ltd. | Expandable stent |
US8277500B2 (en) | 2004-12-17 | 2012-10-02 | Reva Medical, Inc. | Slide-and-lock stent |
US8282680B2 (en) | 2003-01-17 | 2012-10-09 | J. W. Medical Systems Ltd. | Multiple independent nested stent structures and methods for their preparation and deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
US8460358B2 (en) | 2004-03-30 | 2013-06-11 | J.W. Medical Systems, Ltd. | Rapid exchange interventional devices and methods |
US20130172976A1 (en) * | 2005-05-25 | 2013-07-04 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8523936B2 (en) | 2010-04-10 | 2013-09-03 | Reva Medical, Inc. | Expandable slide and lock stent |
US8585747B2 (en) | 2003-12-23 | 2013-11-19 | J.W. Medical Systems Ltd. | Devices and methods for controlling and indicating the length of an interventional element |
US8652198B2 (en) | 2006-03-20 | 2014-02-18 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of linked prosthetic segments |
WO2014028062A1 (en) * | 2012-08-13 | 2014-02-20 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
US20140052232A1 (en) * | 2012-08-10 | 2014-02-20 | Altura Medical, Inc. | Handle assemblies for stent graft delivery systems and associated systems and methods |
WO2013151576A3 (en) * | 2012-04-06 | 2014-03-27 | Abbott Cardiovascular Systems Inc. | Delivery system for segmented scaffolds |
US20140135888A1 (en) * | 2012-11-15 | 2014-05-15 | Palmaz Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
US8795347B2 (en) | 2008-09-25 | 2014-08-05 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US8808347B2 (en) | 2008-09-25 | 2014-08-19 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US20150005870A1 (en) * | 2013-03-15 | 2015-01-01 | W. L. Gore & Associates, Inc. | Self-expanding, balloon expandable stent-grafts |
JP2015503946A (en) * | 2011-12-16 | 2015-02-05 | ストライカー コーポレイションStryker Corporation | Embolization removal cage |
US8979917B2 (en) | 2008-09-25 | 2015-03-17 | Advanced Bifurcation Systems, Inc. | System and methods for treating a bifurcation |
US8986362B2 (en) | 2004-06-28 | 2015-03-24 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US9149378B2 (en) | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9192500B1 (en) | 2015-01-29 | 2015-11-24 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198784B2 (en) | 2005-06-08 | 2015-12-01 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of multiple custom-length prostheses |
US20150366686A1 (en) * | 2013-03-01 | 2015-12-24 | The Regents Of The University Of California | Apparatus and methods for bidirectional hyperelastic stent covers |
US9254210B2 (en) | 2011-02-08 | 2016-02-09 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9364356B2 (en) | 2011-02-08 | 2016-06-14 | Advanced Bifurcation System, Inc. | System and methods for treating a bifurcation with a fully crimped stent |
US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9381103B2 (en) * | 2014-10-06 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Stent with elongating struts |
US9408732B2 (en) | 2013-03-14 | 2016-08-09 | Reva Medical, Inc. | Reduced-profile slide and lock stent |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9456914B2 (en) | 2015-01-29 | 2016-10-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US9730818B2 (en) | 2007-12-12 | 2017-08-15 | Intact Vascular, Inc. | Endoluminal device and method |
US9737424B2 (en) | 2008-09-25 | 2017-08-22 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US20180042740A1 (en) * | 2015-03-03 | 2018-02-15 | Efemoral Medical Llc | Multi-element bioresorbable intravascular stent |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
US10166374B2 (en) | 2015-09-17 | 2019-01-01 | Cagent Vascular, Llc | Wedge dissectors for a medical balloon |
EP3437865A1 (en) * | 2017-07-31 | 2019-02-06 | General Electric Company | Components including structures having decoupled load paths |
WO2019045695A1 (en) * | 2017-08-29 | 2019-03-07 | C.R. Bard, Inc. | Reconfigurable stent, and systems and methods for use thereof |
US10231856B2 (en) | 2016-10-27 | 2019-03-19 | Cook Medical Technologies Llc | Stent with segments capable of uncoupling during expansion |
US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
US10471238B2 (en) | 2014-11-03 | 2019-11-12 | Cagent Vascular, Llc | Serration balloon |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10905863B2 (en) | 2016-11-16 | 2021-02-02 | Cagent Vascular, Llc | Systems and methods of depositing drug into tissue through serrations |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
CN113088759A (en) * | 2021-04-14 | 2021-07-09 | 中国矿业大学 | Low-modulus nontoxic harmless biomedical beta-type titanium alloy and preparation method thereof |
US11219750B2 (en) | 2008-03-21 | 2022-01-11 | Cagent Vascular, Inc. | System and method for plaque serration |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US11369779B2 (en) | 2018-07-25 | 2022-06-28 | Cagent Vascular, Inc. | Medical balloon catheters with enhanced pushability |
US11622872B2 (en) * | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11738181B2 (en) | 2014-06-04 | 2023-08-29 | Cagent Vascular, Inc. | Cage for medical balloon |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6814746B2 (en) * | 2002-11-01 | 2004-11-09 | Ev3 Peripheral, Inc. | Implant delivery system with marker interlock |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US20140107761A1 (en) | 2004-07-26 | 2014-04-17 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US9375215B2 (en) * | 2006-01-20 | 2016-06-28 | W. L. Gore & Associates, Inc. | Device for rapid repair of body conduits |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
WO2008083190A2 (en) | 2006-12-28 | 2008-07-10 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making same |
US20100318171A1 (en) * | 2009-06-15 | 2010-12-16 | Boston Scientific Scimed, Inc. | Multiple Stent Delivery System |
WO2011119573A1 (en) * | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
WO2012154782A1 (en) | 2011-05-11 | 2012-11-15 | Tyco Healthcare Group Lp | Vascular remodeling device |
EP2564812B1 (en) | 2011-08-31 | 2018-12-19 | Cook Medical Technologies LLC | Delivery system for an endoluminal prosthesis |
US8771341B2 (en) * | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
US9072620B2 (en) | 2011-11-04 | 2015-07-07 | Covidien Lp | Protuberant aneurysm bridging device deployment method |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
KR101424201B1 (en) * | 2012-08-14 | 2014-08-13 | 이종훈 | Stent provided with window and graft thereof |
DE102012220129B4 (en) * | 2012-11-05 | 2022-12-15 | Optimed Medizinische Lnstrumente Gmbh | stent |
WO2014105873A1 (en) | 2012-12-26 | 2014-07-03 | Stryker Corporation | Multilayer stent |
CN107530162B (en) * | 2015-05-11 | 2020-01-24 | 曲瓦斯库勒股份有限公司 | Stent graft with improved flexibility |
WO2019033121A1 (en) * | 2017-08-11 | 2019-02-14 | Elixir Medical Corporation | Uncaging stent |
EP3861961A1 (en) * | 2016-05-16 | 2021-08-11 | Elixir Medical Corporation | Uncaging stent |
US11357650B2 (en) | 2019-02-28 | 2022-06-14 | Vesper Medical, Inc. | Hybrid stent |
US11628076B2 (en) | 2017-09-08 | 2023-04-18 | Vesper Medical, Inc. | Hybrid stent |
US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
CN110251284B (en) * | 2019-05-21 | 2021-06-18 | 泰升医疗有限公司 | Expanding stent |
Citations (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069825A (en) * | 1976-01-28 | 1978-01-24 | Taichiro Akiyama | Surgical thread and cutting apparatus for the same |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4564014A (en) * | 1980-01-30 | 1986-01-14 | Thomas J. Fogarty | Variable length dilatation catheter apparatus and method |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4733685A (en) * | 1985-10-10 | 1988-03-29 | Dan Bron | Cyclic flow distributor |
US4739762A (en) * | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4891225A (en) * | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4988356A (en) * | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5092677A (en) * | 1989-08-02 | 1992-03-03 | Artel, Inc. | Photometer having a long lamp life, reduced warm-up period and resonant frequency mixing |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US5282824A (en) * | 1990-10-09 | 1994-02-01 | Cook, Incorporated | Percutaneous stent assembly |
US5300085A (en) * | 1986-04-15 | 1994-04-05 | Advanced Cardiovascular Systems, Inc. | Angioplasty apparatus facilitating rapid exchanges and method |
US5406346A (en) * | 1992-04-20 | 1995-04-11 | Asahi Kogaku Kogyo Kabushiki Kaisha | Adaptor for film cartridge |
US5490837A (en) * | 1991-07-05 | 1996-02-13 | Scimed Life Systems, Inc. | Single operator exchange catheter having a distal catheter shaft section |
US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5507768A (en) * | 1991-01-28 | 1996-04-16 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5593412A (en) * | 1994-03-01 | 1997-01-14 | Cordis Corporation | Stent delivery method and apparatus |
US5607444A (en) * | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US5607463A (en) * | 1993-03-30 | 1997-03-04 | Medtronic, Inc. | Intravascular medical device |
US5709701A (en) * | 1996-05-30 | 1998-01-20 | Parodi; Juan C. | Apparatus for implanting a prothesis within a body passageway |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5722669A (en) * | 1995-09-26 | 1998-03-03 | Keeper Co., Ltd. | Resin CVJ boot with distinct large and small crest portions |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5735869A (en) * | 1994-11-30 | 1998-04-07 | Schneider (Europe) A.G. | Balloon catheter and stent delivery device |
US5741323A (en) * | 1993-04-28 | 1998-04-21 | Focal, Inc. | Polymeric article for intraluminal photothermoforming |
US5855563A (en) * | 1992-11-02 | 1999-01-05 | Localmed, Inc. | Method and apparatus for sequentially performing multiple intraluminal procedures |
US5855125A (en) * | 1995-07-26 | 1999-01-05 | Malden Mills Industries, Inc. | Method for constructing a double face fabric and fabric produced thereby |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US5870381A (en) * | 1995-07-10 | 1999-02-09 | Matsushita Electric Industrial Co., Ltd. | Method for transmitting signals from a plurality of transmitting units and receiving the signals |
US5879370A (en) * | 1994-02-25 | 1999-03-09 | Fischell; Robert E. | Stent having a multiplicity of undulating longitudinals |
US5891190A (en) * | 1989-08-24 | 1999-04-06 | Boneau; Michael D. | Endovascular support device and method |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6022359A (en) * | 1999-01-13 | 2000-02-08 | Frantzen; John J. | Stent delivery system featuring a flexible balloon |
US6033434A (en) * | 1995-06-08 | 2000-03-07 | Ave Galway Limited | Bifurcated endovascular stent and methods for forming and placing |
US6036725A (en) * | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
US6039721A (en) * | 1996-07-24 | 2000-03-21 | Cordis Corporation | Method and catheter system for delivering medication with an everting balloon catheter |
US6042589A (en) * | 1998-03-17 | 2000-03-28 | Medicorp, S.A. | Reversible-action endoprosthesis delivery device |
US6179878B1 (en) * | 1996-10-22 | 2001-01-30 | Thomas Duerig | Composite self expanding stent device having a restraining element |
US6183509B1 (en) * | 1995-05-04 | 2001-02-06 | Alain Dibie | Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device |
US6187034B1 (en) * | 1999-01-13 | 2001-02-13 | John J. Frantzen | Segmented stent for flexible stent delivery system |
US6190402B1 (en) * | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
US6196995B1 (en) * | 1998-09-30 | 2001-03-06 | Medtronic Ave, Inc. | Reinforced edge exchange catheter |
US6200337B1 (en) * | 1996-03-10 | 2001-03-13 | Terumo Kabushiki Kaisha | Implanting stent |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US6344272B1 (en) * | 1997-03-12 | 2002-02-05 | Wm. Marsh Rice University | Metal nanoshells |
US6357104B1 (en) * | 1993-08-18 | 2002-03-19 | David J. Myers | Method of making an intraluminal stent graft |
US6363171B1 (en) * | 1994-01-13 | 2002-03-26 | Stmicroelectronics S.R.L. | Apparatus for recognizing alphanumeric characters |
US20020037358A1 (en) * | 1997-08-13 | 2002-03-28 | Barry James J. | Loading and release of water-insoluble drugs |
US6375676B1 (en) * | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6379365B1 (en) * | 1999-03-29 | 2002-04-30 | Alexis Diaz | Stent delivery catheter system having grooved shaft |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6520986B2 (en) * | 1995-12-14 | 2003-02-18 | Gore Enterprise Holdings, Inc. | Kink resistant stent-graft |
US6520967B1 (en) * | 1999-10-20 | 2003-02-18 | Cauthen Research Group, Inc. | Spinal implant insertion instrument for spinal interbody prostheses |
US6527549B1 (en) * | 2001-09-28 | 2003-03-04 | Guntars Berzins | Two-part dental impression tray |
US20030045923A1 (en) * | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
US6530944B2 (en) * | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US6540777B2 (en) * | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
US6551350B1 (en) * | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US6555157B1 (en) * | 2000-07-25 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Method for coating an implantable device and system for performing the method |
US6676695B2 (en) * | 2001-05-30 | 2004-01-13 | Jan Otto Solem | Vascular instrument and method |
US6679909B2 (en) * | 2001-07-31 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Rapid exchange delivery system for self-expanding stent |
US6685730B2 (en) * | 2001-09-26 | 2004-02-03 | Rice University | Optically-absorbing nanoparticles for enhanced tissue repair |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20040030380A1 (en) * | 2002-04-24 | 2004-02-12 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US6692465B2 (en) * | 1991-06-11 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US6699280B2 (en) * | 1999-04-15 | 2004-03-02 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6699724B1 (en) * | 1998-03-11 | 2004-03-02 | Wm. Marsh Rice University | Metal nanoshells for biosensing applications |
US20040044395A1 (en) * | 2002-09-03 | 2004-03-04 | Scimed Life Systems, Inc. | Elephant trunk thoracic endograft and delivery system |
US6702843B1 (en) * | 2000-04-12 | 2004-03-09 | Scimed Life Systems, Inc. | Stent delivery means with balloon retraction means |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US6709440B2 (en) * | 2001-05-17 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6712845B2 (en) * | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6712827B2 (en) * | 1996-08-23 | 2004-03-30 | Scimed Life Systems, Inc. | Stent delivery system |
US6723071B2 (en) * | 2001-03-14 | 2004-04-20 | Scimed Life Systems, Inc. | Rapid exchange stent delivery system and associated components |
US6837901B2 (en) * | 2001-04-27 | 2005-01-04 | Intek Technology L.L.C. | Methods for delivering, repositioning and/or retrieving self-expanding stents |
US20050010276A1 (en) * | 2001-12-03 | 2005-01-13 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US6849064B2 (en) * | 2002-10-25 | 2005-02-01 | James S. Hamada | Minimal access lumbar diskectomy instrumentation and method |
US6852252B2 (en) * | 1997-03-12 | 2005-02-08 | William Marsh Rice University | Use of metalnanoshells to impede the photo-oxidation of conjugated polymer |
US20050038505A1 (en) * | 2001-11-05 | 2005-02-17 | Sun Biomedical Ltd. | Drug-delivery endovascular stent and method of forming the same |
US6858034B1 (en) * | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US20050049673A1 (en) * | 2001-12-03 | 2005-03-03 | Xtent, Inc. A Delaware Corporation | Apparatus and methods for delivery of braided prostheses |
US7005454B2 (en) * | 1995-07-28 | 2006-02-28 | Rutgers, The State University | Polymeric drug formulations |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US20070027521A1 (en) * | 2005-06-08 | 2007-02-01 | Xtent, Inc., A Delaware Corporation | Apparatus and methods for deployment of multiple custom-length prostheses |
US7192440B2 (en) * | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
US20070067012A1 (en) * | 2001-12-03 | 2007-03-22 | Xtent, Inc. | Custom length stent apparatus |
US7314480B2 (en) * | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
US7323006B2 (en) * | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US7326236B2 (en) * | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US20080077229A1 (en) * | 2004-06-28 | 2008-03-27 | Xtent, Inc. | Custom-length self-expanding stent delivery systems with stent bumpers |
Family Cites Families (340)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468224A (en) | 1982-01-28 | 1984-08-28 | Advanced Cardiovascular Systems, Inc. | System and method for catheter placement in blood vessels of a human patient |
US5693083A (en) | 1983-12-09 | 1997-12-02 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
DE3442736A1 (en) | 1984-11-23 | 1986-06-05 | Tassilo Dr.med. 7800 Freiburg Bonzel | DILATATION CATHETER |
US4690684A (en) | 1985-07-12 | 1987-09-01 | C. R. Bard, Inc. | Meltable stent for anastomosis |
US4770176A (en) | 1985-07-12 | 1988-09-13 | C. R. Bard, Inc. | Vessel anastomosis using meltable stent |
US4681110A (en) | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
US4775337A (en) | 1986-12-02 | 1988-10-04 | Universal Manufacturing Corporation | Conductive wire with integral electrical terminal |
US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
DE3884020T2 (en) | 1987-02-27 | 1994-03-03 | Bard Inc C R | Catheter and guide wire replacement system. |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5171222A (en) | 1988-03-10 | 1992-12-15 | Scimed Life Systems, Inc. | Interlocking peel-away dilation catheter |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US6730105B2 (en) | 1988-07-29 | 2004-05-04 | Samuel Shiber | Clover leaf shaped tubular medical device |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US5226913A (en) | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US4994066A (en) * | 1988-10-07 | 1991-02-19 | Voss Gene A | Prostatic stent |
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
ES2049204T3 (en) | 1989-01-30 | 1994-07-16 | Bard Inc C R | RAPIDLY CHANGEABLE CORONARY CATHETER. |
US5217495A (en) | 1989-05-10 | 1993-06-08 | United States Surgical Corporation | Synthetic semiabsorbable composite yarn |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5158548A (en) | 1990-04-25 | 1992-10-27 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5013318A (en) | 1990-07-31 | 1991-05-07 | Special Devices Incorporated | Medical instrument for measuring depth of fastener hold in bone |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
US5533968A (en) | 1991-05-15 | 1996-07-09 | Advanced Cardiovascular Systems, Inc. | Low profile catheter with expandable outer tubular member |
US5527354A (en) | 1991-06-28 | 1996-06-18 | Cook Incorporated | Stent formed of half-round wire |
US5976107A (en) | 1991-07-05 | 1999-11-02 | Scimed Life Systems. Inc. | Catheter having extendable guide wire lumen |
EP0533960B1 (en) | 1991-07-29 | 1994-10-12 | Brandes, Bernd | Device and procedure for detecting leaks in double walled pipelines for fluids |
US5443498A (en) | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5456713A (en) | 1991-10-25 | 1995-10-10 | Cook Incorporated | Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5628775A (en) | 1991-11-08 | 1997-05-13 | Ep Technologies, Inc. | Flexible bond for sleeves enclosing a bendable electrode tip assembly |
US5192297A (en) * | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
DE69330119T2 (en) | 1992-01-09 | 2001-08-02 | Advanced Cardiovascular System | DEVICE FOR REPLACING A GUIDE WIRE |
US5246421A (en) | 1992-02-12 | 1993-09-21 | Saab Mark A | Method of treating obstructed regions of bodily passages |
US5273536A (en) | 1992-04-02 | 1993-12-28 | Vicky Savas | Tapered balloon catheter |
US5201757A (en) | 1992-04-03 | 1993-04-13 | Schneider (Usa) Inc. | Medial region deployment of radially self-expanding stents |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
DE59206251D1 (en) | 1992-10-31 | 1996-06-13 | Schneider Europ Ag | Arrangement for implanting self-expanding endoprostheses |
CA2149887A1 (en) | 1992-12-30 | 1994-07-21 | Steven J. Healy | Apparatus for deploying body implantable stents |
US5328469A (en) | 1993-03-19 | 1994-07-12 | Roger Coletti | Hybrid balloon angioplasty catheter and methods of use |
US5549553A (en) | 1993-04-29 | 1996-08-27 | Scimed Life Systems, Inc. | Dilation ballon for a single operator exchange intravascular catheter or similar device |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5334187A (en) | 1993-05-21 | 1994-08-02 | Cathco, Inc. | Balloon catheter system with slit opening handle |
US5391172A (en) * | 1993-05-24 | 1995-02-21 | Advanced Cardiovascular Systems, Inc. | Stent delivery system with coaxial catheter handle |
US5458615A (en) | 1993-07-06 | 1995-10-17 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5545209A (en) | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5989280A (en) | 1993-10-22 | 1999-11-23 | Scimed Lifesystems, Inc | Stent delivery apparatus and method |
US5445646A (en) | 1993-10-22 | 1995-08-29 | Scimed Lifesystems, Inc. | Single layer hydraulic sheath stent delivery apparatus and method |
US5549635A (en) | 1994-01-24 | 1996-08-27 | Solar, Rita & Gaterud, Ltd. | Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore |
US6051020A (en) | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
EP0754016B1 (en) | 1994-04-01 | 2003-07-09 | Prograft Medical, Inc. | Self-expandable stent and stent-graft |
US5478349A (en) | 1994-04-28 | 1995-12-26 | Boston Scientific Corporation | Placement of endoprostheses and stents |
WO1995029646A1 (en) | 1994-04-29 | 1995-11-09 | Boston Scientific Corporation | Medical prosthetic stent and method of manufacture |
US5693085A (en) | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
US5456694A (en) | 1994-05-13 | 1995-10-10 | Stentco, Inc. | Device for delivering and deploying intraluminal devices |
US5514093A (en) | 1994-05-19 | 1996-05-07 | Scimed Life Systems, Inc. | Variable length balloon dilatation catheter |
US5683451A (en) | 1994-06-08 | 1997-11-04 | Cardiovascular Concepts, Inc. | Apparatus and methods for deployment release of intraluminal prostheses |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US5636641A (en) | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
US5575816A (en) | 1994-08-12 | 1996-11-19 | Meadox Medicals, Inc. | High strength and high density intraluminal wire stent |
US5470315A (en) | 1994-09-20 | 1995-11-28 | Scimed Life Systems, Inc. | Over-the-wire type balloon catheter with proximal hypotube |
US5702419A (en) | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US5531735A (en) | 1994-09-27 | 1996-07-02 | Hercules Incorporated | Medical devices containing triggerable disintegration agents |
US5549563A (en) | 1994-10-11 | 1996-08-27 | Kronner; Richard F. | Reinforcing insert for uterine manipulator |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
CA2163823A1 (en) | 1994-11-28 | 1996-05-29 | Richard S. Stack | System and method for delivering multiple stents |
US5628755A (en) | 1995-02-20 | 1997-05-13 | Schneider (Europe) A.G. | Balloon catheter and stent delivery system |
CA2163708C (en) | 1994-12-07 | 2007-08-07 | Robert E. Fischell | Integrated dual-function catheter system for balloon angioplasty and stent delivery |
US5549551A (en) | 1994-12-22 | 1996-08-27 | Advanced Cardiovascular Systems, Inc. | Adjustable length balloon catheter |
US5662675A (en) | 1995-02-24 | 1997-09-02 | Intervascular, Inc. | Delivery catheter assembly |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
ATE220308T1 (en) | 1995-03-01 | 2002-07-15 | Scimed Life Systems Inc | LONGITUDONLY FLEXIBLE AND EXPANDABLE STENT |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
CA2218072A1 (en) | 1995-04-14 | 1996-10-17 | Schneider (Usa) Inc. | Rolling membrane stent delivery device |
US5807398A (en) | 1995-04-28 | 1998-09-15 | Shaknovich; Alexander | Shuttle stent delivery catheter |
US5534007A (en) | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5681347A (en) | 1995-05-23 | 1997-10-28 | Boston Scientific Corporation | Vena cava filter delivery system |
WO1996037167A1 (en) | 1995-05-25 | 1996-11-28 | Raychem Corporation | Stent assembly |
US5639274A (en) | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
BR9609355A (en) | 1995-06-06 | 1999-12-21 | Corvita Corp | Endovascular measuring device, unfolding and filling device |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US5797951A (en) | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
US5776141A (en) | 1995-08-28 | 1998-07-07 | Localmed, Inc. | Method and apparatus for intraluminal prosthesis delivery |
DE19531659C2 (en) | 1995-08-29 | 1998-07-02 | Ernst Peter Prof Dr M Strecker | Stent |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US5702418A (en) | 1995-09-12 | 1997-12-30 | Boston Scientific Corporation | Stent delivery system |
EP0851746A1 (en) | 1995-09-18 | 1998-07-08 | W.L. Gore & Associates, Inc. | A delivery system for intraluminal vascular grafts |
US5591195A (en) * | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US5749848A (en) | 1995-11-13 | 1998-05-12 | Cardiovascular Imaging Systems, Inc. | Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US6090063A (en) | 1995-12-01 | 2000-07-18 | C. R. Bard, Inc. | Device, system and method for implantation of filaments and particles in the body |
US6579305B1 (en) | 1995-12-07 | 2003-06-17 | Medtronic Ave, Inc. | Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material |
US6878161B2 (en) | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US5749921A (en) | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
US6533805B1 (en) | 1996-04-01 | 2003-03-18 | General Surgical Innovations, Inc. | Prosthesis and method for deployment within a body lumen |
US5670161A (en) | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US7238197B2 (en) | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
FR2749500B1 (en) | 1996-06-06 | 1998-11-20 | Jacques Seguin | DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION |
US6666883B1 (en) | 1996-06-06 | 2003-12-23 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
DE19630469C2 (en) | 1996-07-27 | 2000-12-21 | Michael Betzler | Vascular endoprosthesis, especially for the endovascular treatment of aortic aneurysms |
US6090136A (en) | 1996-07-29 | 2000-07-18 | Radiance Medical Systems, Inc. | Self expandable tubular support |
US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US6217585B1 (en) | 1996-08-16 | 2001-04-17 | Converge Medical, Inc. | Mechanical stent and graft delivery system |
US6007517A (en) | 1996-08-19 | 1999-12-28 | Anderson; R. David | Rapid exchange/perfusion angioplasty catheter |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
CA2263492C (en) | 1996-08-23 | 2006-10-17 | Scimed Life Systems, Inc. | Stent delivery system having stent securement apparatus |
US20030093143A1 (en) * | 1999-03-01 | 2003-05-15 | Yiju Zhao | Medical device having surface depressions containing nitric oxide releasing compound |
US5921971A (en) | 1996-09-13 | 1999-07-13 | Boston Scientific Corporation | Single operator exchange biliary catheter |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
US5772669A (en) | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US5843119A (en) | 1996-10-23 | 1998-12-01 | United States Surgical Corporation | Apparatus and method for dilatation of a body lumen and delivery of a prothesis therein |
US7220275B2 (en) | 1996-11-04 | 2007-05-22 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
DE59610631D1 (en) | 1996-11-15 | 2003-09-04 | Schneider Europ Gmbh Buelach | Balloon catheter and stent delivery device |
JP3523765B2 (en) | 1997-01-24 | 2004-04-26 | テルモ株式会社 | Living organ dilator |
CN1626048B (en) | 1997-01-24 | 2012-09-12 | 帕拉贡知识产权有限责任公司 | Expandable device having bistable spring construction |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
GB9703859D0 (en) * | 1997-02-25 | 1997-04-16 | Plante Sylvain | Expandable intravascular stent |
US5814064A (en) | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US6035856A (en) | 1997-03-06 | 2000-03-14 | Scimed Life Systems | Percutaneous bypass with branching vessel |
IL128261A0 (en) | 1999-01-27 | 1999-11-30 | Disc O Tech Medical Tech Ltd | Expandable element |
US5817101A (en) | 1997-03-13 | 1998-10-06 | Schneider (Usa) Inc | Fluid actuated stent delivery system |
US5792144A (en) | 1997-03-31 | 1998-08-11 | Cathco, Inc. | Stent delivery catheter system |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6143016A (en) | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
DE59711575D1 (en) | 1997-06-10 | 2004-06-03 | Schneider Europ Gmbh Buelach | catheter system |
US6004328A (en) | 1997-06-19 | 1999-12-21 | Solar; Ronald J. | Radially expandable intraluminal stent and delivery catheter therefore and method of using the same |
FR2764794B1 (en) | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6070589A (en) | 1997-08-01 | 2000-06-06 | Teramed, Inc. | Methods for deploying bypass graft stents |
US5899935A (en) | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US5984957A (en) | 1997-08-12 | 1999-11-16 | Schneider (Usa) Inc | Radially expanded prostheses with axial diameter control |
US6056722A (en) | 1997-09-18 | 2000-05-02 | Iowa-India Investments Company Limited Of Douglas | Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use |
KR20010082497A (en) | 1997-09-24 | 2001-08-30 | 메드 인스티튜트, 인코포레이티드 | Radially expandable stent |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US5961536A (en) | 1997-10-14 | 1999-10-05 | Scimed Life Systems, Inc. | Catheter having a variable length balloon and method of using the same |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
US6027519A (en) * | 1997-12-15 | 2000-02-22 | Stanford; Ulf Harry | Catheter with expandable multiband segment |
US6159178A (en) * | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
ES2252926T3 (en) | 1998-01-26 | 2006-05-16 | Anson Medical Limited | REINFORCED GRAFT. |
US6280467B1 (en) | 1998-02-26 | 2001-08-28 | World Medical Manufacturing Corporation | Delivery system for deployment and endovascular assembly of a multi-stage stented graft |
US6428811B1 (en) | 1998-03-11 | 2002-08-06 | Wm. Marsh Rice University | Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
US6425898B1 (en) | 1998-03-13 | 2002-07-30 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
US6132460A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6558415B2 (en) | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6102942A (en) | 1998-03-30 | 2000-08-15 | Endovascular Technologies, Inc. | Stent/graft deployment catheter with a stent/graft attachment mechanism |
US6063111A (en) | 1998-03-31 | 2000-05-16 | Cordis Corporation | Stent aneurysm treatment system and method |
IE980241A1 (en) * | 1998-04-02 | 1999-10-20 | Salviac Ltd | Delivery catheter with split sheath |
US6037647A (en) | 1998-05-08 | 2000-03-14 | Fujitsu Limited | Semiconductor device having an epitaxial substrate and a fabrication process thereof |
US6171334B1 (en) * | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
DE19829702C1 (en) | 1998-07-03 | 2000-03-16 | Heraeus Gmbh W C | Radially expandable support device V |
WO2000012832A2 (en) | 1998-08-26 | 2000-03-09 | Molecular Geodesics, Inc. | Radially expandable device |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
US5997563A (en) | 1998-09-28 | 1999-12-07 | Medtronic, Inc. | Implantable stent having variable diameter |
US6254612B1 (en) | 1998-10-22 | 2001-07-03 | Cordis Neurovascular, Inc. | Hydraulic stent deployment system |
US6293967B1 (en) * | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
SG75982A1 (en) | 1998-12-03 | 2000-10-24 | Medinol Ltd | Controlled detachment stents |
US6340366B2 (en) * | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
US6350277B1 (en) * | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
CA2359507C (en) | 1999-02-26 | 2005-03-29 | Vascular Architects, Inc. | Catheter assembly with endoluminal prosthesis and method for placing |
US6248122B1 (en) | 1999-02-26 | 2001-06-19 | Vascular Architects, Inc. | Catheter with controlled release endoluminal prosthesis |
US6251134B1 (en) | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US5976155A (en) | 1999-03-05 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | System for removably securing a stent on a catheter assembly and method of use |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6730116B1 (en) | 1999-04-16 | 2004-05-04 | Medtronic, Inc. | Medical device for intraluminal endovascular stenting |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6585756B1 (en) | 1999-05-14 | 2003-07-01 | Ernst P. Strecker | Implantable lumen prosthesis |
US6290673B1 (en) * | 1999-05-20 | 2001-09-18 | Conor Medsystems, Inc. | Expandable medical device delivery system and method |
US6241758B1 (en) | 1999-05-28 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system and method of use |
DE19938377A1 (en) | 1999-08-06 | 2001-03-01 | Biotronik Mess & Therapieg | Stent for vascular branching |
US6415696B1 (en) | 1999-09-01 | 2002-07-09 | Kennametal Pc Inc. | Toolholder assembly |
US6605062B1 (en) | 1999-09-02 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Catheter for guidewire support or exchange |
JP2003521971A (en) | 1999-10-12 | 2003-07-22 | ウィル,アラン アール | Method and apparatus for protecting passages in the body |
US6383171B1 (en) | 1999-10-12 | 2002-05-07 | Allan Will | Methods and devices for protecting a passageway in a body when advancing devices through the passageway |
US6409753B1 (en) | 1999-10-26 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible stent |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6287291B1 (en) | 1999-11-09 | 2001-09-11 | Advanced Cardiovascular Systems, Inc. | Protective sheath for catheters |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
JP4473390B2 (en) | 2000-01-07 | 2010-06-02 | 川澄化学工業株式会社 | Stent and stent graft |
US6322586B1 (en) | 2000-01-10 | 2001-11-27 | Scimed Life Systems, Inc. | Catheter tip designs and method of manufacture |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
EP1251797B1 (en) | 2000-02-04 | 2007-11-28 | Wilson-Cook Medical Inc. | Stent introducer apparatus |
US7373197B2 (en) | 2000-03-03 | 2008-05-13 | Intramedical Imaging, Llc | Methods and devices to expand applications of intraoperative radiation probes |
IL177381A0 (en) | 2000-03-08 | 2006-12-10 | Given Imaging Ltd | A device for in vivo imaging |
DE10012460A1 (en) | 2000-03-15 | 2001-09-20 | Biotronik Mess & Therapieg | Stent consists of several adjacent lengthwise tubular sections joined by first and second connections consisting of cell-type elements of one orientation. |
US6264683B1 (en) | 2000-03-17 | 2001-07-24 | Advanced Cardiovascular Systems, Inc. | Stent delivery catheter with bumpers for improved retention of balloon expandable stents |
AUPQ641400A0 (en) | 2000-03-23 | 2000-04-15 | Kleiner, Daniel E. | A device incorporating a hollow member for being positioned along a body cavity of a patient and method of positioning same |
US6315708B1 (en) | 2000-03-31 | 2001-11-13 | Cordis Corporation | Stent with self-expanding end sections |
US6964676B1 (en) | 2000-04-14 | 2005-11-15 | Scimed Life Systems, Inc. | Stent securement system |
US6451050B1 (en) | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
AU2001257326A1 (en) | 2000-04-28 | 2001-11-12 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
AU2001259429A1 (en) | 2000-05-02 | 2001-11-12 | Wilson-Cook Medical Inc. | Introducer device for catheters o.t.l. with eversible sleeve |
US6602282B1 (en) | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
JP4754714B2 (en) * | 2000-06-01 | 2011-08-24 | テルモ株式会社 | Intraluminal indwelling |
US6569180B1 (en) | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6540775B1 (en) * | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
US6773446B1 (en) | 2000-08-02 | 2004-08-10 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6629992B2 (en) | 2000-08-04 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Sheath for self-expanding stent |
AU2002212621A1 (en) * | 2000-09-14 | 2002-03-26 | Tuborg Engineering Nv | Adaptive balloon with improved flexibility |
US6945989B1 (en) | 2000-09-18 | 2005-09-20 | Endotex Interventional Systems, Inc. | Apparatus for delivering endoluminal prostheses and methods of making and using them |
CA2643556C (en) | 2000-09-22 | 2011-08-16 | Boston Scientific Limited | Flexible and expandable stent |
US6589273B1 (en) | 2000-10-02 | 2003-07-08 | Impra, Inc. | Apparatus and method for relining a blood vessel |
US6602226B1 (en) | 2000-10-12 | 2003-08-05 | Scimed Life Systems, Inc. | Low-profile stent delivery system and apparatus |
WO2002059226A2 (en) | 2000-11-03 | 2002-08-01 | Wm. Marsh Rice University | Partial coverage metal nanoshells and method of making same |
US6582394B1 (en) | 2000-11-14 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcated vessels |
US6743251B1 (en) | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
US6607553B1 (en) | 2000-11-17 | 2003-08-19 | B. Braun Medical, Inc. | Method for deploying a thermo-mechanically expandable stent |
US6582460B1 (en) | 2000-11-20 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | System and method for accurately deploying a stent |
US6884257B1 (en) | 2000-11-28 | 2005-04-26 | Advanced Cardiovascular Systems, Inc. | Stent delivery system with adjustable length balloon |
US6468298B1 (en) | 2000-12-28 | 2002-10-22 | Advanced Cardiovascular Systems, Inc. | Gripping delivery system for self-expanding stents and method of using the same |
DE10103000B4 (en) | 2001-01-24 | 2007-08-30 | Qualimed Innovative Medizinprodukte Gmbh | Radially re-expandable vascular support |
DE10105160B4 (en) | 2001-02-06 | 2005-09-01 | Osypka, Peter, Dr.-Ing. | Implantable vascular support |
DE50210591D1 (en) | 2001-02-16 | 2007-09-13 | Abbott Lab Vascular Entpr Ltd | IMPLANTS WITH FK506 FOR RESTENOSIS TREATMENT AND PROPHYLAXIS |
US20030097169A1 (en) | 2001-02-26 | 2003-05-22 | Brucker Gregory G. | Bifurcated stent and delivery system |
US7799064B2 (en) | 2001-02-26 | 2010-09-21 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US20020123786A1 (en) | 2001-03-02 | 2002-09-05 | Ventrica, Inc. | Methods and devices for bypassing an obstructed target vessel by placing the vessel in communication with a heart chamber containing blood |
ES2739875T3 (en) | 2001-03-13 | 2020-02-04 | Medinol Ltd | Endoprosthesis to improve blood flow |
EP1258230A3 (en) | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US6660031B2 (en) | 2001-04-11 | 2003-12-09 | Scimed Life Systems, Inc. | Multi-length delivery system |
GB0110551D0 (en) | 2001-04-30 | 2001-06-20 | Angiomed Ag | Self-expanding stent delivery service |
EP1254644A1 (en) * | 2001-05-01 | 2002-11-06 | Pan Medical Limited | Variable form stent and deployment arrangement for use therewith |
US8337540B2 (en) | 2001-05-17 | 2012-12-25 | Advanced Cardiovascular Systems, Inc. | Stent for treating bifurcations and method of use |
US6562067B2 (en) | 2001-06-08 | 2003-05-13 | Cordis Corporation | Stent with interlocking elements |
US6676693B1 (en) * | 2001-06-27 | 2004-01-13 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for delivering a self-expanding stent |
DE60120955T3 (en) | 2001-07-20 | 2015-06-25 | Cid S.P.A. | stent |
US6599296B1 (en) | 2001-07-27 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Ratcheting handle for intraluminal catheter systems |
US6796999B2 (en) | 2001-09-06 | 2004-09-28 | Medinol Ltd. | Self articulating stent |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US20030055485A1 (en) | 2001-09-17 | 2003-03-20 | Intra Therapeutics, Inc. | Stent with offset cell geometry |
US6778316B2 (en) | 2001-10-24 | 2004-08-17 | William Marsh Rice University | Nanoparticle-based all-optical sensors |
JP4043216B2 (en) | 2001-10-30 | 2008-02-06 | オリンパス株式会社 | Stent |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US8353945B2 (en) | 2001-12-03 | 2013-01-15 | J.W. Medical System Ltd. | Delivery catheter having active engagement mechanism for prosthesis |
US8080048B2 (en) | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7270668B2 (en) | 2001-12-03 | 2007-09-18 | Xtent, Inc. | Apparatus and methods for delivering coiled prostheses |
US20030114919A1 (en) | 2001-12-10 | 2003-06-19 | Mcquiston Jesse | Polymeric stent with metallic rings |
US6991646B2 (en) * | 2001-12-18 | 2006-01-31 | Linvatec Biomaterials, Inc. | Method and apparatus for delivering a stent into a body lumen |
WO2003053284A1 (en) * | 2001-12-20 | 2003-07-03 | White Geoffrey H | An intraluminal stent and graft |
US7537607B2 (en) | 2001-12-21 | 2009-05-26 | Boston Scientific Scimed, Inc. | Stent geometry for improved flexibility |
JP2005515031A (en) | 2002-01-16 | 2005-05-26 | イーバ コーポレイション | Catheter handpiece device and method of using the device |
US6939368B2 (en) | 2002-01-17 | 2005-09-06 | Scimed Life Systems, Inc. | Delivery system for self expanding stents for use in bifurcated vessels |
US6981985B2 (en) | 2002-01-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Stent bumper struts |
US6911040B2 (en) | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
US7029493B2 (en) * | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
US6866679B2 (en) | 2002-03-12 | 2005-03-15 | Ev3 Inc. | Everting stent and stent delivery system |
GB0206061D0 (en) | 2002-03-14 | 2002-04-24 | Angiomed Ag | Metal structure compatible with MRI imaging, and method of manufacturing such a structure |
US6800065B2 (en) | 2002-04-04 | 2004-10-05 | Medtronic Ave, Inc. | Catheter and guide wire exchange system |
US7052511B2 (en) | 2002-04-04 | 2006-05-30 | Scimed Life Systems, Inc. | Delivery system and method for deployment of foreshortening endoluminal devices |
US20030195609A1 (en) | 2002-04-10 | 2003-10-16 | Scimed Life Systems, Inc. | Hybrid stent |
US7648515B2 (en) | 2002-04-16 | 2010-01-19 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including an expandable anchor |
US7470281B2 (en) | 2002-04-26 | 2008-12-30 | Medtronic Vascular, Inc. | Coated stent with crimpable coating |
US6645547B1 (en) | 2002-05-02 | 2003-11-11 | Labcoat Ltd. | Stent coating device |
US20030225446A1 (en) | 2002-05-29 | 2003-12-04 | William A. Cook Australia Pty Ltd. | Multi-piece prosthesis deployment apparatus |
US7056523B1 (en) | 2002-06-21 | 2006-06-06 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine |
US6761734B2 (en) | 2002-07-22 | 2004-07-13 | William S. Suhr | Segmented balloon catheter for stenting bifurcation lesions |
US20040015224A1 (en) * | 2002-07-22 | 2004-01-22 | Armstrong Joseph R. | Endoluminal expansion system |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
US6945995B2 (en) | 2002-08-29 | 2005-09-20 | Boston Scientific Scimed, Inc. | Stent overlap point markers |
US6951053B2 (en) | 2002-09-04 | 2005-10-04 | Reva Medical, Inc. | Method of manufacturing a prosthesis |
US6893417B2 (en) | 2002-09-20 | 2005-05-17 | Medtronic Vascular, Inc. | Catheter and guide wire exchange system with improved proximal shaft and transition section |
JP4033747B2 (en) | 2002-09-30 | 2008-01-16 | テルモ株式会社 | Biological organ expansion device |
US7223283B2 (en) | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
US6994721B2 (en) * | 2002-10-21 | 2006-02-07 | Israel Henry M | Stent assembly |
US7169172B2 (en) * | 2002-11-01 | 2007-01-30 | Counter Clockwise, Inc. | Method and apparatus for caged stent delivery |
WO2004043300A1 (en) | 2002-11-07 | 2004-05-27 | Abbott Laboratories | Prosthesis with multiple drugs in discrete unmixed droplets |
KR20130032407A (en) | 2002-11-08 | 2013-04-01 | 코너 메드시스템즈, 엘엘씨 | Method and apparatus for reducing tissue damage after ischemic injury |
ITRM20020596A1 (en) | 2002-11-27 | 2004-05-28 | Mauro Ferrari | IMPLANT VASCULAR PROSTHESIS WITH COMBINED, LAPAROSCOPIC AND ENDOVASCULAR TECHNIQUES, FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS, AND OPERATIONAL EQUIPMENT FOR THE RELEASE OF A PROSTHESIS EQUIPPED WITH ANCHORING STENTS. |
US9408731B2 (en) | 2002-12-04 | 2016-08-09 | Cook Medical Technologies Llc | Method and device for treating aortic dissection |
US20040172127A1 (en) | 2002-12-09 | 2004-09-02 | John Kantor | Modular stent having polymer bridges at modular unit contact sites |
US6849084B2 (en) * | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
EP2226040A1 (en) | 2003-03-26 | 2010-09-08 | Cardiomind, Inc. | Stent delivery system with torsionally compressed stent |
WO2004093746A1 (en) | 2003-03-26 | 2004-11-04 | The Foundry Inc. | Devices and methods for treatment of abdominal aortic aneurysm |
US7208001B2 (en) | 2003-04-24 | 2007-04-24 | Medtronic Vascular, Inc. | Catheter with detached proximal inflation and guidewire shafts |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7131993B2 (en) | 2003-06-25 | 2006-11-07 | Boston Scientific Scimed, Inc. | Varying circumferential spanned connectors in a stent |
US7744620B2 (en) | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
US8784472B2 (en) * | 2003-08-15 | 2014-07-22 | Boston Scientific Scimed, Inc. | Clutch driven stent delivery system |
US20050209674A1 (en) | 2003-09-05 | 2005-09-22 | Kutscher Tuvia D | Balloon assembly (V) |
US20070219613A1 (en) | 2003-10-06 | 2007-09-20 | Xtent, Inc. | Apparatus and methods for interlocking stent segments |
US7553324B2 (en) | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US20050080475A1 (en) | 2003-10-14 | 2005-04-14 | Xtent, Inc. A Delaware Corporation | Stent delivery devices and methods |
US7175654B2 (en) * | 2003-10-16 | 2007-02-13 | Cordis Corporation | Stent design having stent segments which uncouple upon deployment |
US20050085897A1 (en) | 2003-10-17 | 2005-04-21 | Craig Bonsignore | Stent design having independent stent segments which uncouple upon deployment |
US20050123451A1 (en) | 2003-10-31 | 2005-06-09 | Hiroshi Nomura | System and apparatus for body fluid analysis using surface-textured optical materials |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
US7090694B1 (en) | 2003-11-19 | 2006-08-15 | Advanced Cardiovascular Systems, Inc. | Portal design for stent for treating bifurcated vessels |
US8157855B2 (en) | 2003-12-05 | 2012-04-17 | Boston Scientific Scimed, Inc. | Detachable segment stent |
US7244336B2 (en) | 2003-12-17 | 2007-07-17 | Lam Research Corporation | Temperature controlled hot edge ring assembly for reducing plasma reactor etch rate drift |
US9232948B2 (en) | 2003-12-23 | 2016-01-12 | Stryker Corporation | Catheter with distal occlusion apparatus |
US20070156225A1 (en) | 2003-12-23 | 2007-07-05 | Xtent, Inc. | Automated control mechanisms and methods for custom length stent apparatus |
US20050149168A1 (en) | 2003-12-30 | 2005-07-07 | Daniel Gregorich | Stent to be deployed on a bend |
US20050222671A1 (en) | 2004-03-31 | 2005-10-06 | Schaeffer Darin G | Partially biodegradable stent |
US20050228477A1 (en) | 2004-04-09 | 2005-10-13 | Xtent, Inc. | Topographic coatings and coating methods for medical devices |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US20050278011A1 (en) | 2004-06-10 | 2005-12-15 | Peckham John E | Stent delivery system |
JP4844394B2 (en) * | 2004-06-25 | 2011-12-28 | 日本ゼオン株式会社 | Stent |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
EP1827304B1 (en) | 2004-10-25 | 2011-04-20 | Merit Medical Systems, Inc. | Stent removal and repositioning device |
US7402168B2 (en) | 2005-04-11 | 2008-07-22 | Xtent, Inc. | Custom-length stent delivery system with independently operable expansion elements |
US8460357B2 (en) | 2005-05-31 | 2013-06-11 | J.W. Medical Systems Ltd. | In situ stent formation |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US8021426B2 (en) | 2005-06-15 | 2011-09-20 | Ouroboros Medical, Inc. | Mechanical apparatus and method for artificial disc replacement |
JP4797473B2 (en) * | 2005-07-11 | 2011-10-19 | ニプロ株式会社 | Flexible stent with excellent expandability |
US20080249607A1 (en) | 2005-09-20 | 2008-10-09 | Thomas Jay Webster | Biocompatable Nanophase Materials |
US20070179587A1 (en) | 2006-01-30 | 2007-08-02 | Xtent, Inc. | Apparatus and methods for deployment of custom-length prostheses |
JP2009530060A (en) | 2006-03-20 | 2009-08-27 | エックステント・インコーポレーテッド | Apparatus and method for deploying connected prosthetic segments |
US20070265637A1 (en) | 2006-04-21 | 2007-11-15 | Xtent, Inc. | Devices and methods for controlling and counting interventional elements |
US20070281117A1 (en) | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
ATE515996T1 (en) | 2006-06-30 | 2011-07-15 | Boston Scient Ltd | STENT DESIGN WITH VARIABLE EXPANSION COLUMNS AROUND THE CIRCUMFERENCE |
US20080269865A1 (en) | 2006-08-07 | 2008-10-30 | Xtent, Inc. | Custom Length Stent Apparatus |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US9370642B2 (en) | 2007-06-29 | 2016-06-21 | J.W. Medical Systems Ltd. | Adjustable-length drug delivery balloon |
US20090076584A1 (en) | 2007-09-19 | 2009-03-19 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses |
-
2003
- 2003-12-16 US US10/738,666 patent/US20040186551A1/en not_active Abandoned
-
2008
- 2008-04-03 US US12/061,951 patent/US20080208318A1/en not_active Abandoned
- 2008-04-25 US US12/109,477 patent/US20080208311A1/en not_active Abandoned
-
2009
- 2009-06-26 US US12/492,828 patent/US8282680B2/en not_active Expired - Lifetime
-
2012
- 2012-08-30 US US13/599,957 patent/US8740968B2/en not_active Expired - Fee Related
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069825A (en) * | 1976-01-28 | 1978-01-24 | Taichiro Akiyama | Surgical thread and cutting apparatus for the same |
US4564014A (en) * | 1980-01-30 | 1986-01-14 | Thomas J. Fogarty | Variable length dilatation catheter apparatus and method |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4891225A (en) * | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4733685A (en) * | 1985-10-10 | 1988-03-29 | Dan Bron | Cyclic flow distributor |
US4739762B1 (en) * | 1985-11-07 | 1998-10-27 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4739762A (en) * | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5501227A (en) * | 1986-04-15 | 1996-03-26 | Yock; Paul G. | Angioplasty apparatus facilitating rapid exchange and method |
US5300085A (en) * | 1986-04-15 | 1994-04-05 | Advanced Cardiovascular Systems, Inc. | Angioplasty apparatus facilitating rapid exchanges and method |
US4988356A (en) * | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5092677A (en) * | 1989-08-02 | 1992-03-03 | Artel, Inc. | Photometer having a long lamp life, reduced warm-up period and resonant frequency mixing |
US5891190A (en) * | 1989-08-24 | 1999-04-06 | Boneau; Michael D. | Endovascular support device and method |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5282824A (en) * | 1990-10-09 | 1994-02-01 | Cook, Incorporated | Percutaneous stent assembly |
US5507768A (en) * | 1991-01-28 | 1996-04-16 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US6527789B1 (en) * | 1991-01-28 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US6692465B2 (en) * | 1991-06-11 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5490837A (en) * | 1991-07-05 | 1996-02-13 | Scimed Life Systems, Inc. | Single operator exchange catheter having a distal catheter shaft section |
US5406346A (en) * | 1992-04-20 | 1995-04-11 | Asahi Kogaku Kogyo Kabushiki Kaisha | Adaptor for film cartridge |
US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5855563A (en) * | 1992-11-02 | 1999-01-05 | Localmed, Inc. | Method and apparatus for sequentially performing multiple intraluminal procedures |
US5607463A (en) * | 1993-03-30 | 1997-03-04 | Medtronic, Inc. | Intravascular medical device |
US5741323A (en) * | 1993-04-28 | 1998-04-21 | Focal, Inc. | Polymeric article for intraluminal photothermoforming |
US6357104B1 (en) * | 1993-08-18 | 2002-03-19 | David J. Myers | Method of making an intraluminal stent graft |
US5607444A (en) * | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US6363171B1 (en) * | 1994-01-13 | 2002-03-26 | Stmicroelectronics S.R.L. | Apparatus for recognizing alphanumeric characters |
US5879370A (en) * | 1994-02-25 | 1999-03-09 | Fischell; Robert E. | Stent having a multiplicity of undulating longitudinals |
US5593412A (en) * | 1994-03-01 | 1997-01-14 | Cordis Corporation | Stent delivery method and apparatus |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5735869A (en) * | 1994-11-30 | 1998-04-07 | Schneider (Europe) A.G. | Balloon catheter and stent delivery device |
US6183509B1 (en) * | 1995-05-04 | 2001-02-06 | Alain Dibie | Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device |
US6033434A (en) * | 1995-06-08 | 2000-03-07 | Ave Galway Limited | Bifurcated endovascular stent and methods for forming and placing |
US5870381A (en) * | 1995-07-10 | 1999-02-09 | Matsushita Electric Industrial Co., Ltd. | Method for transmitting signals from a plurality of transmitting units and receiving the signals |
US5855125A (en) * | 1995-07-26 | 1999-01-05 | Malden Mills Industries, Inc. | Method for constructing a double face fabric and fabric produced thereby |
US7005454B2 (en) * | 1995-07-28 | 2006-02-28 | Rutgers, The State University | Polymeric drug formulations |
US5722669A (en) * | 1995-09-26 | 1998-03-03 | Keeper Co., Ltd. | Resin CVJ boot with distinct large and small crest portions |
US6520986B2 (en) * | 1995-12-14 | 2003-02-18 | Gore Enterprise Holdings, Inc. | Kink resistant stent-graft |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6200337B1 (en) * | 1996-03-10 | 2001-03-13 | Terumo Kabushiki Kaisha | Implanting stent |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US5709701A (en) * | 1996-05-30 | 1998-01-20 | Parodi; Juan C. | Apparatus for implanting a prothesis within a body passageway |
US6190402B1 (en) * | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
US6039721A (en) * | 1996-07-24 | 2000-03-21 | Cordis Corporation | Method and catheter system for delivering medication with an everting balloon catheter |
US6712827B2 (en) * | 1996-08-23 | 2004-03-30 | Scimed Life Systems, Inc. | Stent delivery system |
US6179878B1 (en) * | 1996-10-22 | 2001-01-30 | Thomas Duerig | Composite self expanding stent device having a restraining element |
US6551350B1 (en) * | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US6344272B1 (en) * | 1997-03-12 | 2002-02-05 | Wm. Marsh Rice University | Metal nanoshells |
US6852252B2 (en) * | 1997-03-12 | 2005-02-08 | William Marsh Rice University | Use of metalnanoshells to impede the photo-oxidation of conjugated polymer |
US20020037358A1 (en) * | 1997-08-13 | 2002-03-28 | Barry James J. | Loading and release of water-insoluble drugs |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6699724B1 (en) * | 1998-03-11 | 2004-03-02 | Wm. Marsh Rice University | Metal nanoshells for biosensing applications |
US6042589A (en) * | 1998-03-17 | 2000-03-28 | Medicorp, S.A. | Reversible-action endoprosthesis delivery device |
US6036725A (en) * | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
US6196995B1 (en) * | 1998-09-30 | 2001-03-06 | Medtronic Ave, Inc. | Reinforced edge exchange catheter |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US6022359A (en) * | 1999-01-13 | 2000-02-08 | Frantzen; John J. | Stent delivery system featuring a flexible balloon |
US6187034B1 (en) * | 1999-01-13 | 2001-02-13 | John J. Frantzen | Segmented stent for flexible stent delivery system |
US6379365B1 (en) * | 1999-03-29 | 2002-04-30 | Alexis Diaz | Stent delivery catheter system having grooved shaft |
US6699280B2 (en) * | 1999-04-15 | 2004-03-02 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6375676B1 (en) * | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6858034B1 (en) * | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US6520967B1 (en) * | 1999-10-20 | 2003-02-18 | Cauthen Research Group, Inc. | Spinal implant insertion instrument for spinal interbody prostheses |
US6530944B2 (en) * | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US6702843B1 (en) * | 2000-04-12 | 2004-03-09 | Scimed Life Systems, Inc. | Stent delivery means with balloon retraction means |
US6555157B1 (en) * | 2000-07-25 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Method for coating an implantable device and system for performing the method |
US6540777B2 (en) * | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
US6723071B2 (en) * | 2001-03-14 | 2004-04-20 | Scimed Life Systems, Inc. | Rapid exchange stent delivery system and associated components |
US6712845B2 (en) * | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6837901B2 (en) * | 2001-04-27 | 2005-01-04 | Intek Technology L.L.C. | Methods for delivering, repositioning and/or retrieving self-expanding stents |
US6709440B2 (en) * | 2001-05-17 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6676695B2 (en) * | 2001-05-30 | 2004-01-13 | Jan Otto Solem | Vascular instrument and method |
US6679909B2 (en) * | 2001-07-31 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Rapid exchange delivery system for self-expanding stent |
US20030045923A1 (en) * | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
US6685730B2 (en) * | 2001-09-26 | 2004-02-03 | Rice University | Optically-absorbing nanoparticles for enhanced tissue repair |
US6527549B1 (en) * | 2001-09-28 | 2003-03-04 | Guntars Berzins | Two-part dental impression tray |
US20050038505A1 (en) * | 2001-11-05 | 2005-02-17 | Sun Biomedical Ltd. | Drug-delivery endovascular stent and method of forming the same |
US7182779B2 (en) * | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US20050010276A1 (en) * | 2001-12-03 | 2005-01-13 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US20050049673A1 (en) * | 2001-12-03 | 2005-03-03 | Xtent, Inc. A Delaware Corporation | Apparatus and methods for delivery of braided prostheses |
US20070067012A1 (en) * | 2001-12-03 | 2007-03-22 | Xtent, Inc. | Custom length stent apparatus |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20040030380A1 (en) * | 2002-04-24 | 2004-02-12 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20040044395A1 (en) * | 2002-09-03 | 2004-03-04 | Scimed Life Systems, Inc. | Elephant trunk thoracic endograft and delivery system |
US6849064B2 (en) * | 2002-10-25 | 2005-02-01 | James S. Hamada | Minimal access lumbar diskectomy instrumentation and method |
US7314480B2 (en) * | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
US7192440B2 (en) * | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
US7326236B2 (en) * | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7323006B2 (en) * | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20080077229A1 (en) * | 2004-06-28 | 2008-03-27 | Xtent, Inc. | Custom-length self-expanding stent delivery systems with stent bumpers |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US20070027521A1 (en) * | 2005-06-08 | 2007-02-01 | Xtent, Inc., A Delaware Corporation | Apparatus and methods for deployment of multiple custom-length prostheses |
US7320702B2 (en) * | 2005-06-08 | 2008-01-22 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses (III) |
US20080071345A1 (en) * | 2005-06-08 | 2008-03-20 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses (iii) |
Cited By (261)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7722662B2 (en) | 1998-02-17 | 2010-05-25 | Reva Medical, Inc. | Expandable stent with sliding and locking radial elements |
US10912665B2 (en) | 2001-03-29 | 2021-02-09 | J.W. Medical Systems Ltd. | Balloon catheter for multiple adjustable stent deployment |
US9980839B2 (en) | 2001-03-29 | 2018-05-29 | J.W. Medical Systems Ltd. | Balloon catheter for multiple adjustable stent deployment |
US8142487B2 (en) | 2001-03-29 | 2012-03-27 | Xtent, Inc. | Balloon catheter for multiple adjustable stent deployment |
US9119739B2 (en) | 2001-03-29 | 2015-09-01 | J.W. Medical Systems Ltd. | Balloon catheter for multiple adjustable stent deployment |
US8147536B2 (en) | 2001-03-29 | 2012-04-03 | Xtent, Inc. | Balloon catheter for multiple adjustable stent deployment |
US8257427B2 (en) | 2001-09-11 | 2012-09-04 | J.W. Medical Systems, Ltd. | Expandable stent |
US8070789B2 (en) | 2001-12-03 | 2011-12-06 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US8177831B2 (en) | 2001-12-03 | 2012-05-15 | Xtent, Inc. | Stent delivery apparatus and method |
US8956398B2 (en) | 2001-12-03 | 2015-02-17 | J.W. Medical Systems Ltd. | Custom length stent apparatus |
US7892274B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US20070100424A1 (en) * | 2001-12-03 | 2007-05-03 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US8702781B2 (en) | 2001-12-03 | 2014-04-22 | J.W. Medical Systems Ltd. | Apparatus and methods for delivery of multiple distributed stents |
US7905913B2 (en) | 2001-12-03 | 2011-03-15 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7922755B2 (en) | 2001-12-03 | 2011-04-12 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US8574282B2 (en) | 2001-12-03 | 2013-11-05 | J.W. Medical Systems Ltd. | Apparatus and methods for delivery of braided prostheses |
US7938852B2 (en) | 2001-12-03 | 2011-05-10 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US8016871B2 (en) | 2001-12-03 | 2011-09-13 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US8016870B2 (en) | 2001-12-03 | 2011-09-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US8080048B2 (en) | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US8083788B2 (en) | 2001-12-03 | 2011-12-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US9326876B2 (en) | 2001-12-03 | 2016-05-03 | J.W. Medical Systems Ltd. | Apparatus and methods for delivery of multiple distributed stents |
US20030130683A1 (en) * | 2001-12-03 | 2003-07-10 | Xtent, Inc., | Apparatus and methods for delivering coiled prostheses |
US8740968B2 (en) | 2003-01-17 | 2014-06-03 | J.W. Medical Systems Ltd. | Multiple independent nested stent structures and methods for their preparation and deployment |
US8282680B2 (en) | 2003-01-17 | 2012-10-09 | J. W. Medical Systems Ltd. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7918881B2 (en) | 2003-06-09 | 2011-04-05 | Xtent, Inc. | Stent deployment systems and methods |
US20050017540A1 (en) * | 2003-07-22 | 2005-01-27 | Leigh Arthur Donald | Caravan |
US20050085897A1 (en) * | 2003-10-17 | 2005-04-21 | Craig Bonsignore | Stent design having independent stent segments which uncouple upon deployment |
US8585747B2 (en) | 2003-12-23 | 2013-11-19 | J.W. Medical Systems Ltd. | Devices and methods for controlling and indicating the length of an interventional element |
US9566179B2 (en) | 2003-12-23 | 2017-02-14 | J.W. Medical Systems Ltd. | Devices and methods for controlling and indicating the length of an interventional element |
US8460358B2 (en) | 2004-03-30 | 2013-06-11 | J.W. Medical Systems, Ltd. | Rapid exchange interventional devices and methods |
US9700448B2 (en) | 2004-06-28 | 2017-07-11 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
WO2006005082A2 (en) | 2004-06-28 | 2006-01-12 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8986362B2 (en) | 2004-06-28 | 2015-03-24 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8512394B2 (en) | 2004-07-21 | 2013-08-20 | Reva Medical Inc. | Balloon expandable crush-recoverable stent device |
US7763065B2 (en) | 2004-07-21 | 2010-07-27 | Reva Medical, Inc. | Balloon expandable crush-recoverable stent device |
JP4892485B2 (en) * | 2004-09-27 | 2012-03-07 | エックステント・インコーポレーテッド | Self-constrained segmented stents and methods for their deployment |
WO2006036939A3 (en) * | 2004-09-27 | 2007-05-24 | Xtent Inc | Self-constrained segmented stents and methods for their deployment |
WO2006036939A2 (en) | 2004-09-27 | 2006-04-06 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US8292944B2 (en) | 2004-12-17 | 2012-10-23 | Reva Medical, Inc. | Slide-and-lock stent |
US9173751B2 (en) | 2004-12-17 | 2015-11-03 | Reva Medical, Inc. | Slide-and-lock stent |
US8277500B2 (en) | 2004-12-17 | 2012-10-02 | Reva Medical, Inc. | Slide-and-lock stent |
US20120102708A1 (en) * | 2005-02-25 | 2012-05-03 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis and methods of use |
US8603154B2 (en) * | 2005-02-25 | 2013-12-10 | Abbott Laboratories Vascular Enterprises Limited | Modular vascular prosthesis and methods of use |
US7837726B2 (en) | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
US20070213810A1 (en) * | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
US20130172976A1 (en) * | 2005-05-25 | 2013-07-04 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US9204983B2 (en) * | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10322018B2 (en) * | 2005-05-25 | 2019-06-18 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US20160151184A1 (en) * | 2005-05-25 | 2016-06-02 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10064747B2 (en) | 2005-05-25 | 2018-09-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9381104B2 (en) | 2005-05-25 | 2016-07-05 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US20060271151A1 (en) * | 2005-05-31 | 2006-11-30 | Xtent, Inc. | In situ stent formation |
US8460357B2 (en) | 2005-05-31 | 2013-06-11 | J.W. Medical Systems Ltd. | In situ stent formation |
US11439524B2 (en) | 2005-06-08 | 2022-09-13 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of multiple custom-length prostheses (III) |
US9198784B2 (en) | 2005-06-08 | 2015-12-01 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of multiple custom-length prostheses |
US10219923B2 (en) | 2005-06-08 | 2019-03-05 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of multiple custom-length prostheses (III) |
EP1749545A2 (en) * | 2005-07-29 | 2007-02-07 | Cordis Corporation | System for treating aneurysmal disease |
EP1749545A3 (en) * | 2005-07-29 | 2007-03-21 | Cordis Corporation | System for treating aneurysmal disease |
US7914574B2 (en) | 2005-08-02 | 2011-03-29 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US9149378B2 (en) | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8617235B2 (en) | 2005-08-02 | 2013-12-31 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8562666B2 (en) | 2005-09-28 | 2013-10-22 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
JP2007090074A (en) * | 2005-09-28 | 2007-04-12 | Nitinol Dev Corp | Intraluminal medical instrument superposedly connected to one another |
EP1769779A3 (en) * | 2005-09-28 | 2007-04-11 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
EP1769779A2 (en) * | 2005-09-28 | 2007-04-04 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
US20100010622A1 (en) * | 2006-03-13 | 2010-01-14 | Abbott Laboratories | Hybrid segmented endoprosthesis |
US20140236282A1 (en) * | 2006-03-20 | 2014-08-21 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of linked prosthetic segments |
US9883957B2 (en) * | 2006-03-20 | 2018-02-06 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of linked prosthetic segments |
US8652198B2 (en) | 2006-03-20 | 2014-02-18 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of linked prosthetic segments |
US8043358B2 (en) * | 2006-03-29 | 2011-10-25 | Boston Scientific Scimed, Inc. | Stent with overlap and high extension |
US20070233270A1 (en) * | 2006-03-29 | 2007-10-04 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
US8348991B2 (en) | 2006-03-29 | 2013-01-08 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
US20070239257A1 (en) * | 2006-03-29 | 2007-10-11 | Jan Weber | Stent with overlap and high extension |
WO2007143609A2 (en) | 2006-06-02 | 2007-12-13 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US20070288076A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Biological tissue stimulator with flexible electrode carrier |
US20070288077A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Self-anchoring electrical lead with multiple electrodes |
US20070288183A1 (en) * | 2006-06-07 | 2007-12-13 | Cherik Bulkes | Analog signal transition detector |
US8540762B2 (en) | 2007-01-26 | 2013-09-24 | Reva Medical, Inc. | Circumferentially nested expandable device |
US8172894B2 (en) | 2007-01-26 | 2012-05-08 | Reva Medical, Inc. | Circumferentially nested expandable device |
US7704275B2 (en) | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
US9457133B2 (en) | 2007-02-20 | 2016-10-04 | J.W. Medical Systems Ltd. | Thermo-mechanically controlled implants and methods of use |
WO2008103741A1 (en) | 2007-02-20 | 2008-08-28 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8980297B2 (en) | 2007-02-20 | 2015-03-17 | J.W. Medical Systems Ltd. | Thermo-mechanically controlled implants and methods of use |
US9339404B2 (en) | 2007-03-22 | 2016-05-17 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20100274114A1 (en) * | 2007-06-07 | 2010-10-28 | Denker Stephen T | Signal sensing in an implanted apparatus with an internal reference |
US8366628B2 (en) | 2007-06-07 | 2013-02-05 | Kenergy, Inc. | Signal sensing in an implanted apparatus with an internal reference |
US9144487B2 (en) | 2007-06-11 | 2015-09-29 | Abbott Cardiovascular Systems Inc. | Polymer-bioceramic composite medical devices with bioceramic particles having grafted polymers |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
US9144508B2 (en) * | 2007-07-19 | 2015-09-29 | Back Bay Medical Inc. | Radially expandable stent |
US20090024205A1 (en) * | 2007-07-19 | 2009-01-22 | Bay Street Medical | Radially Expandable Stent |
WO2009012417A1 (en) * | 2007-07-19 | 2009-01-22 | Bay Street Medical, Inc. | Radially expandable stent |
US9314354B2 (en) | 2007-11-30 | 2016-04-19 | Reva Medical, Inc. | Axially-radially nested expandable device |
US7988721B2 (en) | 2007-11-30 | 2011-08-02 | Reva Medical, Inc. | Axially-radially nested expandable device |
US8460363B2 (en) | 2007-11-30 | 2013-06-11 | Reva Medical, Inc. | Axially-radially nested expandable device |
US10188533B2 (en) * | 2007-12-12 | 2019-01-29 | Intact Vascular, Inc. | Minimal surface area contact device for holding plaque to blood vessel wall |
US10660771B2 (en) | 2007-12-12 | 2020-05-26 | Intact Vacsular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US20120083872A1 (en) * | 2007-12-12 | 2012-04-05 | Peter Schneider | Device and method for tacking plaque to a blood vessel wall |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US9730818B2 (en) | 2007-12-12 | 2017-08-15 | Intact Vascular, Inc. | Endoluminal device and method |
US9974670B2 (en) * | 2007-12-12 | 2018-05-22 | Intact Vascular, Inc. | Method of treating atherosclerotic occlusive disease |
US10299945B2 (en) | 2007-12-12 | 2019-05-28 | Intact Vascular, Inc. | Method of treating atherosclerotic occlusive disease |
US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
US10117762B2 (en) | 2007-12-12 | 2018-11-06 | Intact Vascular, Inc. | Endoluminal device and method |
US10799374B2 (en) | 2007-12-12 | 2020-10-13 | Intact Vascular, Inc. | Device and method for tacking plaque to blood vessel wall |
US9545322B2 (en) | 2007-12-12 | 2017-01-17 | Intact Vascular, Inc. | Device and method for tacking plaque to blood vessel wall |
US10835395B2 (en) | 2007-12-12 | 2020-11-17 | Intact Vascular, Inc. | Method of treating atherosclerotic occlusive disease |
US20110004237A1 (en) * | 2007-12-12 | 2011-01-06 | Peter Schneider | Minimal surface area contact device for holding plaque to blood vessel wall |
US10278839B2 (en) | 2007-12-12 | 2019-05-07 | Intact Vascular, Inc. | Endovascular impant |
US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US20100262225A1 (en) * | 2007-12-12 | 2010-10-14 | Peter Schneider | Device and method for tacking plaque to a blood vessel wall |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
US20090157159A1 (en) * | 2007-12-12 | 2009-06-18 | Peter Schneider | Device and method for tacking plaque to blood vessel wall |
US20090171449A1 (en) * | 2008-01-02 | 2009-07-02 | Yunbing Wang | Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles |
US7935143B2 (en) * | 2008-01-02 | 2011-05-03 | Abbott Cardiovascular Systems Inc. | Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles |
US8043367B2 (en) | 2008-01-02 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Stents formed from polymer-bioceramic composite with radiopaque bioceramic particles |
US20110172758A1 (en) * | 2008-01-02 | 2011-07-14 | Yunbing Wang | Stents Formed From Polymer-Bioceramic Composite With Radiopaque Bioceramic Particles |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US9393386B2 (en) | 2008-03-21 | 2016-07-19 | Cagent Vascular, Llc | Intravascular device |
US11529501B2 (en) | 2008-03-21 | 2022-12-20 | Gagent Vascular, Inc. | System and method for plaque serration |
US9480826B2 (en) | 2008-03-21 | 2016-11-01 | Cagent Vascular, Llc | Intravascular device |
US20090240270A1 (en) * | 2008-03-21 | 2009-09-24 | Peter Schneider | Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque |
US11141573B2 (en) | 2008-03-21 | 2021-10-12 | Cagent Vascular, Inc. | Method for plaque serration |
US11229777B2 (en) | 2008-03-21 | 2022-01-25 | Cagent Vascular, Inc. | System and method for plaque serration |
US20100042121A1 (en) * | 2008-03-21 | 2010-02-18 | Peter Schneider | Pre-angioplasty serration of atherosclerotic plaque enabling low-pressure balloon angioplasty and avoidance of stenting |
US8323243B2 (en) | 2008-03-21 | 2012-12-04 | Innovasc Llc | Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque |
US11219750B2 (en) | 2008-03-21 | 2022-01-11 | Cagent Vascular, Inc. | System and method for plaque serration |
US11166742B2 (en) | 2008-03-21 | 2021-11-09 | Cagent Vascular, Inc. | Method of enhancing drug uptake from a drug-eluting balloon |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US10610389B2 (en) | 2008-05-13 | 2020-04-07 | Covidien Lp | Braid implant delivery systems |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US8979917B2 (en) | 2008-09-25 | 2015-03-17 | Advanced Bifurcation Systems, Inc. | System and methods for treating a bifurcation |
US8795347B2 (en) | 2008-09-25 | 2014-08-05 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US8828071B2 (en) | 2008-09-25 | 2014-09-09 | Advanced Bifurcation Systems, Inc. | Methods and systems for ostial stenting of a bifurcation |
US9855158B2 (en) | 2008-09-25 | 2018-01-02 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US11000392B2 (en) | 2008-09-25 | 2021-05-11 | Advanced Bifurcation Systems Inc. | Partially crimped stent |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US9730821B2 (en) | 2008-09-25 | 2017-08-15 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US8808347B2 (en) | 2008-09-25 | 2014-08-19 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US10918506B2 (en) | 2008-09-25 | 2021-02-16 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation |
US9737424B2 (en) | 2008-09-25 | 2017-08-22 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US10610391B2 (en) | 2008-09-25 | 2020-04-07 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US9724218B2 (en) | 2008-09-25 | 2017-08-08 | Advanced Bifurcation Systems, Inc. | Methods and systems for ostial stenting of a bifurcation |
US10219927B2 (en) | 2008-09-25 | 2019-03-05 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
US10219926B2 (en) | 2008-09-25 | 2019-03-05 | Advanced Bifurcation Systems Inc. | Selective stent crimping |
US11426297B2 (en) | 2008-09-25 | 2022-08-30 | Advanced Bifurcation Systems Inc. | Selective stent crimping |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US11839562B2 (en) | 2008-09-25 | 2023-12-12 | Advanced Bifurcation Systems Inc. | Partially crimped stent |
US11857442B2 (en) | 2008-09-25 | 2024-01-02 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation |
US8545547B2 (en) | 2008-10-10 | 2013-10-01 | Reva Medical Inc. | Expandable slide and lock stent |
US9066827B2 (en) | 2008-10-10 | 2015-06-30 | Reva Medical, Inc. | Expandable slide and lock stent |
US7947071B2 (en) | 2008-10-10 | 2011-05-24 | Reva Medical, Inc. | Expandable slide and lock stent |
AU2009311658B2 (en) * | 2008-11-06 | 2013-06-27 | Cook Medical Technologies Llc | Stent member |
US8092516B2 (en) | 2008-11-06 | 2012-01-10 | Cook Medical Technologies Llc | Stent member |
JP2012507387A (en) * | 2008-11-06 | 2012-03-29 | ウィリアム クック ユーロープ アーペーエス | Stent member |
US20100114294A1 (en) * | 2008-11-06 | 2010-05-06 | William Cook Europe Aps | Stent Member |
WO2010053563A1 (en) * | 2008-11-06 | 2010-05-14 | William Cook Europe Aps | Stent member |
WO2010129846A1 (en) * | 2009-05-08 | 2010-11-11 | Synthes Usa, Llc | Expandable bone implant |
US20100286782A1 (en) * | 2009-05-08 | 2010-11-11 | Konrad Schaller | Expandable bone implant |
US9216023B2 (en) | 2009-05-08 | 2015-12-22 | DePuy Synthes Products, Inc. | Expandable bone implant |
US9925055B2 (en) | 2009-05-08 | 2018-03-27 | DePuy Synthes Products, Inc. | Expandable bone implant |
US10646349B2 (en) | 2009-05-08 | 2020-05-12 | DePuy Synthes Products, Inc. | Expandable bone implant |
US20110230954A1 (en) * | 2009-06-11 | 2011-09-22 | Peter Schneider | Stent device having focal elevating elements for minimal surface area contact with lumen walls |
US10779971B2 (en) | 2009-06-11 | 2020-09-22 | Intact Vascular, Inc. | Endovascular implant |
US10888443B2 (en) | 2009-06-11 | 2021-01-12 | Intact Vascular, Inc. | Device for holding plaque to blood vessel wall |
US10413340B2 (en) | 2009-08-19 | 2019-09-17 | DePuy Synthes Products, Inc. | Method and apparatus for augmenting bone |
US11576704B2 (en) | 2009-08-19 | 2023-02-14 | DePuy Synthes Products, Inc. | Method and apparatus for augmenting bone |
US9247970B2 (en) | 2009-08-19 | 2016-02-02 | DePuy Synthes Products, Inc. | Method and apparatus for augmenting bone |
US20110046737A1 (en) * | 2009-08-19 | 2011-02-24 | Jacques Teisen | Method and apparatus for augmenting bone |
US9987055B2 (en) | 2009-08-19 | 2018-06-05 | DePuy Synthes Products, Inc. | Method and apparatus for augmenting bone |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US8523936B2 (en) | 2010-04-10 | 2013-09-03 | Reva Medical, Inc. | Expandable slide and lock stent |
US9452068B2 (en) | 2010-04-10 | 2016-09-27 | Reva Medical, Inc. | Expandable slide and lock stent |
US10137013B2 (en) | 2010-05-29 | 2018-11-27 | Intact Vascular, Inc. | Endoluminal device and method |
US10779968B2 (en) | 2010-05-29 | 2020-09-22 | Intact Vascular, Inc. | Endoluminal device and method |
US11717428B2 (en) | 2011-02-08 | 2023-08-08 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation with a fully crimped stent |
US10406010B2 (en) | 2011-02-08 | 2019-09-10 | Advanced Bifurcation Systems Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
US9364356B2 (en) | 2011-02-08 | 2016-06-14 | Advanced Bifurcation System, Inc. | System and methods for treating a bifurcation with a fully crimped stent |
US11000393B2 (en) | 2011-02-08 | 2021-05-11 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation with a fully crimped stent |
US10285832B2 (en) | 2011-02-08 | 2019-05-14 | Advanced Bifurcation Systems Inc. | System and methods for treating a bifurcation with a fully crimped stent |
US9254210B2 (en) | 2011-02-08 | 2016-02-09 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
US11484424B2 (en) | 2011-02-08 | 2022-11-01 | Advanced Bifurcation Systems Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
US10779969B2 (en) | 2011-06-03 | 2020-09-22 | Intact Vascular, Inc. | Endovascular implant and deployment devices |
US10285831B2 (en) | 2011-06-03 | 2019-05-14 | Intact Vascular, Inc. | Endovascular implant |
US10390977B2 (en) | 2011-06-03 | 2019-08-27 | Intact Vascular, Inc. | Endovascular implant |
US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
EP2790598B1 (en) * | 2011-12-16 | 2017-04-26 | Stryker Corporation | Embolectomy cage |
US9439750B2 (en) | 2011-12-16 | 2016-09-13 | Stryker Corporation | Embolectomy cage |
JP2015503946A (en) * | 2011-12-16 | 2015-02-05 | ストライカー コーポレイションStryker Corporation | Embolization removal cage |
US9254212B2 (en) | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
WO2013151576A3 (en) * | 2012-04-06 | 2014-03-27 | Abbott Cardiovascular Systems Inc. | Delivery system for segmented scaffolds |
US9895244B2 (en) | 2012-04-06 | 2018-02-20 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US9877856B2 (en) | 2012-07-18 | 2018-01-30 | Covidien Lp | Methods and apparatus for luminal stenting |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140052232A1 (en) * | 2012-08-10 | 2014-02-20 | Altura Medical, Inc. | Handle assemblies for stent graft delivery systems and associated systems and methods |
WO2014028062A1 (en) * | 2012-08-13 | 2014-02-20 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
JP2015529102A (en) * | 2012-08-13 | 2015-10-05 | アボット カルディオバスキュラー システムズ インコーポレーテッドAbbott Cardiovascular Systems Inc. | Segmented scaffold structure |
US9585779B2 (en) | 2012-08-13 | 2017-03-07 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
CN104540477A (en) * | 2012-08-13 | 2015-04-22 | 艾博特心血管系统公司 | Segmented scaffold designs |
US9585778B2 (en) | 2012-08-13 | 2017-03-07 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
US8834556B2 (en) * | 2012-08-13 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Segmented scaffold designs |
US10433989B2 (en) | 2012-11-15 | 2019-10-08 | Vactronix Scientific, Llc | Stents having a hybrid pattern and methods of manufacture |
US11701246B2 (en) | 2012-11-15 | 2023-07-18 | Vactronix Scientific, Llc. | Stents having a hybrid pattern and methods of manufacture |
US20140135888A1 (en) * | 2012-11-15 | 2014-05-15 | Palmaz Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
USD887003S1 (en) | 2012-11-15 | 2020-06-09 | Vactronix Scientific, Llc | Hybrid patterned stent device |
US9566633B2 (en) * | 2012-11-15 | 2017-02-14 | Vactronix Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
US10085862B2 (en) * | 2013-03-01 | 2018-10-02 | The Regents Of The University Of California | Apparatus and methods for bidirectional hyperelastic stent covers |
US20150366686A1 (en) * | 2013-03-01 | 2015-12-24 | The Regents Of The University Of California | Apparatus and methods for bidirectional hyperelastic stent covers |
US10835400B2 (en) | 2013-03-01 | 2020-11-17 | The Regents Of The University Of California | Apparatus and methods for bidirectional hyperelastic stent covers |
US9408732B2 (en) | 2013-03-14 | 2016-08-09 | Reva Medical, Inc. | Reduced-profile slide and lock stent |
US20150005870A1 (en) * | 2013-03-15 | 2015-01-01 | W. L. Gore & Associates, Inc. | Self-expanding, balloon expandable stent-grafts |
US10905539B2 (en) * | 2013-03-15 | 2021-02-02 | W. L. Gore & Associates, Inc. | Self-expanding, balloon expandable stent-grafts |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US11738181B2 (en) | 2014-06-04 | 2023-08-29 | Cagent Vascular, Inc. | Cage for medical balloon |
US9381103B2 (en) * | 2014-10-06 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Stent with elongating struts |
US10471238B2 (en) | 2014-11-03 | 2019-11-12 | Cagent Vascular, Llc | Serration balloon |
US11298513B2 (en) | 2014-11-03 | 2022-04-12 | Cagent Vascular, Inc. | Serration balloon |
US11701502B2 (en) | 2014-11-03 | 2023-07-18 | Cagent Vascular, Inc. | Serration balloon |
US11040178B2 (en) | 2014-11-03 | 2021-06-22 | Cagent Vascular, Llc | Serration balloon |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11304836B2 (en) | 2015-01-29 | 2022-04-19 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10610392B2 (en) | 2015-01-29 | 2020-04-07 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10245167B2 (en) | 2015-01-29 | 2019-04-02 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375337B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10898356B2 (en) | 2015-01-29 | 2021-01-26 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9602786B2 (en) | 2015-01-29 | 2017-03-21 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9345603B1 (en) | 2015-01-29 | 2016-05-24 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9320632B1 (en) | 2015-01-29 | 2016-04-26 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9445929B2 (en) | 2015-01-29 | 2016-09-20 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9585782B2 (en) | 2015-01-29 | 2017-03-07 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9584777B2 (en) | 2015-01-29 | 2017-02-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9456914B2 (en) | 2015-01-29 | 2016-10-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9192500B1 (en) | 2015-01-29 | 2015-11-24 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10660772B2 (en) * | 2015-03-03 | 2020-05-26 | Efemoral Medical Llc | Multi-element bioresorbable intravascular stent |
US20180042740A1 (en) * | 2015-03-03 | 2018-02-15 | Efemoral Medical Llc | Multi-element bioresorbable intravascular stent |
US11717654B2 (en) | 2015-09-17 | 2023-08-08 | Cagent Vascular, Inc. | Wedge dissectors for a medical balloon |
US10689154B2 (en) | 2015-09-17 | 2020-06-23 | Cagent Vascular, Llc | Wedge dissectors for a medical balloon |
US11266819B2 (en) | 2015-09-17 | 2022-03-08 | Cagent Vascular, Inc. | Wedge dissectors for a medical balloon |
US11491314B2 (en) | 2015-09-17 | 2022-11-08 | Cagent Vascular Lac. | Wedge dissectors for a medical balloon |
US10166374B2 (en) | 2015-09-17 | 2019-01-01 | Cagent Vascular, Llc | Wedge dissectors for a medical balloon |
US11266818B2 (en) | 2015-09-17 | 2022-03-08 | Cagent Vascular, Inc. | Wedge dissectors for a medical balloon |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11622872B2 (en) * | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
US10231856B2 (en) | 2016-10-27 | 2019-03-19 | Cook Medical Technologies Llc | Stent with segments capable of uncoupling during expansion |
US10905863B2 (en) | 2016-11-16 | 2021-02-02 | Cagent Vascular, Llc | Systems and methods of depositing drug into tissue through serrations |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10832753B2 (en) | 2017-07-31 | 2020-11-10 | General Electric Company | Components including structures having decoupled load paths |
EP3437865A1 (en) * | 2017-07-31 | 2019-02-06 | General Electric Company | Components including structures having decoupled load paths |
WO2019045695A1 (en) * | 2017-08-29 | 2019-03-07 | C.R. Bard, Inc. | Reconfigurable stent, and systems and methods for use thereof |
US11369779B2 (en) | 2018-07-25 | 2022-06-28 | Cagent Vascular, Inc. | Medical balloon catheters with enhanced pushability |
CN113088759A (en) * | 2021-04-14 | 2021-07-09 | 中国矿业大学 | Low-modulus nontoxic harmless biomedical beta-type titanium alloy and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
US8282680B2 (en) | 2012-10-09 |
US20080208311A1 (en) | 2008-08-28 |
US8740968B2 (en) | 2014-06-03 |
US20080208318A1 (en) | 2008-08-28 |
US20090264979A1 (en) | 2009-10-22 |
US20130060321A1 (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8740968B2 (en) | Multiple independent nested stent structures and methods for their preparation and deployment | |
US6520987B1 (en) | Expandable intravascular stent | |
US7959669B2 (en) | Bifurcated stent with open ended side branch support | |
CA2598164C (en) | Expandable medical device with differential hinge performance | |
EP2231079B1 (en) | Stent | |
EP1933761B1 (en) | Inflatable bifurcation stent | |
EP1940315B1 (en) | Stent with expanding side branch geometry | |
EP2658485B1 (en) | Stent | |
EP2063809B1 (en) | Stent having end section with constant strut lengths, transitional section and middle section with variable strut lengths | |
JP2009507558A (en) | Overlapping stent | |
EP2841024B1 (en) | Support for treating vascular bifurcations | |
EP2642946B1 (en) | Support for treating vascular bifurcations | |
CA2630913A1 (en) | Improved connectors for bifurcated stent | |
US20070208414A1 (en) | Tapered strength rings on a bifurcated stent petal | |
EP2088963B1 (en) | Bifurcation stent design with over expansion capability | |
EP1827303B1 (en) | Vulnerable plaque stent | |
EP2081521B1 (en) | Self-expanding side branch bifurcated stent | |
US20230131129A1 (en) | Stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: XTENT, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KAO, STEPHEN;REEL/FRAME:015387/0611 Effective date: 20040521 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |